Sample metering volume detection
The diagnostic system with dual fluid detection sensors and a sonicator in a cartridge ensures accurate sample volume detection and agitation for nucleic acid analysis, addressing false negatives and enhancing efficiency.
Patent Information
- Application Number
- PCT/US2025/028151
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-05-07
- Publication Date
- 2026-11-12
AI Technical Summary
Existing systems for nucleic acid analysis in biological samples face challenges in ensuring the sufficient volume of the sample is accurately detected and transferred for reliable analysis, leading to potential false negatives and inefficiencies.
A diagnostic system with a cartridge and instrument that uses dual fluid detection sensors in a metering channel to confirm the sample volume is sufficient for analysis by detecting fluid at upstream and downstream locations, and a sonicator to agitate the sample in a lysis chamber for nucleic acid release.
Ensures accurate and efficient sample volume confirmation, reducing false negatives and saving analysis time by aborting insufficient samples early, while providing a reliable and automated sample-to-answer process.
Smart Images

Figure US2025028151_12112026_PF_FP_ABST
Abstract
Description
Atty. Dkt. No.: 86357077SAMPLE METERING VOLUME DETECTION BACKGROUND
[0001] A presence of nucleic acids (e.g., DNA and RNA) in a biological sample or specimen may be useful in diagnosing patients. For example, a presence or amount of a certain nucleic acid may indicate infection or other illness or disease. Preparation of the biological sample may allow the biological sample to be amplified so that an increased number of the nucleic acids proportional to the starting amount of nucleic acids can be detected. Amplification of the nucleic acids may be performed through a method such as a polymerase chain reaction. Detection of the nucleic acids may indicate a presence, absence, or amount of the nucleic acid present in the biological sample.SUMMARY OF THE INVENTION
[0002] This disclosure relates to systems and method for determining an amount of sample fluid supplied to a lysis chamber of a diagnostic cartridge.
[0003] At least one aspect relates to a diagnostic system including an instrument to interface with a cartridge. The instrument includes a pump, a sonicator, a first fluid detection sensor to detect fluid at a first detection location in a fluidic channel of the cartridge and generate first sensor data, a second fluid detection sensor to detect fluid at a second detection location in the fluidic channel downstream of the first detection location and generate second sensor data, and a controller to cause the pump to move at least a portion of a sample fluid in a first fluid chamber of the cartridge through the fluidic channel, determine, based on the first sensor data and the second sensor data, whether at least the portion of the sample fluid is simultaneously detected by the first fluid detection sensor and the second fluid detection sensor, based on determining that at least the portion of the sample fluid is simultaneously detected by the first fluid detection sensor and the second fluid detection sensor, cause the pump to move at least the portion of the sample fluid into a lysis chamber of the cartridge and responsive to moving at least the portion of the sample fluid into a lysis chamber, cause the sonicator to agitate at least the portion of the sample fluid in the lysis chamber.-1- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0004] At least one aspect relates to a method including moving at least a portion of the sample fluid through a fluidic channel in a downstream direction over a first detection location and to a second detection location downstream of the first detection location, monitoring first sensor data from a first fluid detection sensor positioned to detect fluid at the first detection location, monitoring second sensor data from a second fluid detection sensor positioned to detect fluid at the second detection location, determining, based on the first sensor data and the second sensor data, that at least the portion of the sample fluid is detected simultaneously at the first detection location and the second detection location, based on determining that at least the portion of the sample fluid is detected simultaneously at the first detection location and the second detection location, moving at least the portion of the sample fluid into a lysis chamber fluidly coupled to the fluidic channel downstream of the second detection location, and agitating the fluid in the lysis chamber.
[0005] At least one aspect relates to a diagnostic system including a cartridge and an instrument to interface with the cartridge. The cartridge includes a sample input chamber to receive a sample fluid, a lysis chamber, and a fluidic channel fluidly coupling the sample input chamber and the lysis chamber. The instrument includes a pump, a sonicator, a first sensor to detect a wetness value of a first detection location in the fluidic channel; a second sensor to detect a wetness value of a second detection location in the fluidic channel, and a controller to cause the pump to move at least a portion of the sample fluid through the fluidic channel, receive first sensor data from the first sensor including the wetness value of the first detection location over time and second sensor data from the second sensor including the wetness value of the second detection location over time, determine, based on the first sensor data and the second sensor data, whether the wetness value of the first detection location exceeds a first threshold and the wetness value of the second detection location exceeds a second threshold simultaneously, based on determining that the wetness value of the first detection location exceeds the first threshold and the wetness value of the second detection location exceeds the second threshold simultaneously, cause the pump to move at least the portion of the sample fluid into the lysis chamber, and cause the sonicator to agitate at least the portion of the sample fluid in the lysis chamber.-2- 4923-4563-8928.1Atty. Dkt. No.: 86357077BRIEF DESCRIPTION OF THE DRAWINGS
[0006] These and other aspects and features of the present implementations are depicted by way of example in the figures discussed herein. Present implementations can be directed to, but are not limited to, examples depicted in the figures discussed herein. Thus, this disclosure is not limited to any figure or portion thereof depicted or referenced herein, or any aspect described herein with respect to any figures depicted or referenced herein.
[0007] FIG. 1 depicts a block diagram of a diagnostic system according to an example implementation.
[0008] FIG. 2 depicts a block diagram of a diagnostic system according to another example implementation.
[0009] FIG. 3 depicts a method of detecting a presence, absence, or amount of a nucleic acid of interest, in accordance with example implementations.
[0010] FIG. 4 depicts a cartridge architecture, in accordance with example implementations.
[0011] FIG. 5 depicts a method of detecting a presence, absence, or amount of a nucleic acid of interest, in accordance with example implementations.
[0012] FIG. 6 depicts a cartridge with a metering channel completely filled with sample fluid, in accordance with example implementations.
[0013] FIG. 7 is a graph indicating sensor measurements of fluid detection sensors aligned with locations in the metering channel of FIG. 6.
[0014] FIG. 8 depicts a cartridge with a metering channel partially filled with sample fluid, in accordance with example implementations.
[0015] FIG. 9 is a graph indicating sensor measurements of fluid detection sensors aligned with locations in the metering channel of FIG. 8.
[0016] FIG. 10 depicts a cartridge with a metering channel partially filled with sample fluid, in accordance with example implementations.-3- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0017] FIG. 11 is a graph indicating sensor measurements of fluid detection sensors aligned with locations in the metering channel of FIG. 10.
[0018] FIG. 12 depicts a cartridge with a metering channel partially filled with sample fluid, in accordance with example implementations.
[0019] FIG. 13 is a graph indicating sensor measurements of fluid detection sensors aligned with locations in the metering channel of FIG. 12.
[0020] FIG. 14 depicts a cartridge with an empty metering channel, in accordance with example implementations.
[0021] FIG. 15 is a graph indicating sensor measurements of fluid detection sensors aligned with locations in the metering channel of FIG. 14.
[0022] FIG. 16 depicts a method for metering fluid into a lysis chamber in accordance with example implementations.
[0023] It will be recognized that the figures are schematic representations of examples for purposes of illustration. The figures are provided for the purpose of illustrating example implementations with the explicit understanding that the figures will not be used to limit the scope of the meaning of the claims. Thus, the description is not limited to the examples and / or implementations provided in the drawings.DETAILED DESCRIPTION
[0024] Biological samples may contain molecules or particles that are of interest. For example, the molecules may be indicative of disease, illness, genetic abnormalities, etc. Molecular diagnostics may be of use to accurately diagnose potential infections or other diseases. Molecular detection may be performed by amplifying a molecule of interest (also referred to as a “target” or “target molecule”) in the biological sample and detecting a presence, absence, and / or amount of the molecule of interest. In various examples, the molecule of interest may be a nucleic acid. The systems and methods described herein provide rapid, low-cost, point-of-care molecular diagnostics. The systems and methods may be convenient to both health care providers running the diagnostics and patients waiting to be diagnosed. The systems and -4- 4923-4563-8928.1Atty. Dkt. No.: 86357077methods described herein may utilize pulse-controlled amplification (PCA) to amplify and subsequently detect molecules of interest that may be found in a biological sample. PCA reactions may enable rapid thermocycling with a low power expenditure by using paramagnetic particles to concentrate DNA or other nucleic acid targets into a thin thermocycling zone. Additionally, PCA utilizes polymerase chain reaction (PCR) chemistry to replicate and amplify target molecules (e.g., nucleic acids of interest, such as DNA or RNA). Additionally, the diagnostics are performed in a low-cost, disposable cartridge that provides an automated sample-to-answer process. Further, the systems and methods described herein reduce power consumption of instruments used to carry out a multiplex reaction by utilizing low power, yet solid-state and rapid, thermocycling for PCR.
[0025] In one example, a cartridge can include a sample input chamber to input a biological sample containing the nucleic acids of interest (a sample fluid). The biological sample may be, for example, saliva, blood, cells, etc. and may include biological cells. The cartridge can also include a buffer fluid chamber storing buffer fluid (or system composition) that can be mixed with the sample to aid in the analysis processes. For example, the buffer fluid may improve a lysis process in which biological cells in the sample fluid are lysed to release nucleic acids and may improve a hybridization processes in which the nucleic acids in the sample fluid are hybridized to capture oligonucleotides. The buffer fluid may include ingredients (e.g., a tris buffer) to control a pH of the mixture of buffer fluid and sample fluid, and may include water, a salt, and / or a surfactant. The sample input chamber and the buffer fluid chamber may each be fluidly coupled to a lysis chamber via a metering channel. In the lysis chamber, the sample and the buffer fluid may be mixed, and the cells in the biological sample may be lysed as discussed above to release the nucleic acid of interest. For example, a sonicator may generate ultrasonic waves in the lysis chamber to agitate the sample and lyse the cells. The lysed sample may then be moved to a different portion of the cartridge for further analysis.
[0026] The reliability of the analysis of the sample may depend in part on the volume of the sample. For example, if the volume of a sample is below a threshold volume, the sample analysis may not reliably detect nucleic acids of interest that are in fact present in the sample. When the analysis is used, for example, for the purpose of detecting a disease, this may cause a false negative result. By ensuring that the volume of the sample is above a threshold volume-5- 4923-4563-8928.1Atty. Dkt. No.: 86357077and is thus sufficient for analysis, the rate of false negatives, false positives, or inconclusive results can be reduced or minimized.
[0027] In one aspect, a system implementing the systems and methods described herein can determine that the sample fluid inserted into a test cartridge is of sufficient volume for analysis. Other systems may have included visual indicators in a sample input chamber that a user of the instrument may use to visually confirm that the sample is of sufficient volume. However, this is subject to human error, as the user may misread the indicator or fail to check the volume altogether. Further, this visual indicator does not provide any feedback as to whether the sample in the sample input chamber is actually moved through the cartridge to downstream processes. Thus, user may not know until running the entire analysis process whether the sample was stuck in the sample input chamber and not analyzed. Similar problems arise with sensors configured only to measure the volume of fluid in the sample input chamber.
[0028] To overcome these deficiencies, the cartridge described herein can include two sensors in a metering channel respectively configured to detect fluid (e.g., sample fluid) at an upstream detection location in the metering channel and a downstream detection location in the metering channel. The metering channel may fluidly couple a sample input chamber to a lysis chamber, where the sample may be agitated, for example, to lyse biological cells in the sample. As used herein, the term “fluidly couple” “or fluidly coupled” means that two or more fluid transmitting volumes are connected directly to one another or are connected to one another by intermediate volumes or spaces such that fluid may flow from one volume into the other volume. Sensor data from these sensors may be used to confirm that the volume of the sample is sufficient for analysis and has been moved out of the sample input chamber. For example, the volume of the metering channel between the upstream detection location and the downstream detection location may exceed a target or threshold sample fluid volume, and if the sample is detected at both sensors simultaneously and the upstream sensor has not detected any air pockets, the system may confirm that the volume of the sample or portion of the sample in the metering channel fills the entire channel between the upstream detection location and the downstream detection location and thus exceeds the target or threshold volume. Thus, the system may automatically confirm that enough sample is present to successfully process and complete the PCA analysis and confirm that a sufficient volume of the sample is moved into the lysis-6- 4923-4563-8928.1Atty. Dkt. No.: 86357077chamber. This may allow the test to be stopped early if an error is detected or the sample volume is insufficient. For example, a full analysis of a sample may take over twenty minutes, while the sample volume check may take place in the first one or two minutes of the analysis. Thus, if it can be determined that the sample is insufficient in the first two minutes, over eighteen minutes of time can be saved by aborting the analysis. The system can also account for bubbles or air pockets in the sample by providing additional sample to the metering channel and the lysis chamber when a bubble or air pocket is detected. The system can also provide a more accurate measurement of sample volume than a visual indicator and can allow the user to decide whether to proceed with the analysis if the sample is below a target or threshold volume.
[0029] The cartridge can be inserted into an instrument when the process is ready to begin, and the cartridge may only need to be removed from the instrument upon completion of the processes without any external fluid or reagents being added to the process. The cartridge may include valves for controlling flow within fluidic channels of the cartridge. The instrument may include a valve actuator associated with each of the valves, which may selectively control the valves to open and close, for example, using pneumatic pressure, magnets, solenoids, etc. Further, the instrument may include a pump to cause fluid flow through the cartridge. Further, all reagents, reactants, and other components used during the processes, including the buffer fluid, may be stored in and disposed of on the cartridge. The cartridge used to perform the processes herein may be a single use cartridge. Thus, each component (e.g., reagents) needed for the various reactions and processes may be stored on the cartridge.
[0030] Referring now to FIG. 1, a diagnostic system 100 A including a cartridge 100 (e.g., a diagnostic cartridge) and an instrument 150 is shown, according to an example. The cartridge 100 includes a first fluid chamber 143 (e.g., a sample input chamber) fluidly coupled to a lysis chamber 145 by a fluidic channel 147 (e.g., a metering channel). The fluidic channel 147 may define a downstream direction from the first fluid chamber 143 to the lysis chamber 145. A sample fluid (e.g., a biological sample) may be inserted into the cartridge 100, which may be inserted into and interface with the instrument 150. As discussed above, it may be important to ensure that the volume of the sample provided to the lysis chamber 145 and to downstream processes in order for the 100A to provide a reliable analysis of the sample. In various examples, the instrument 150 may be configured to interface with the cartridge 100 to-7- 4923-4563-8928.1Atty. Dkt. No.: 86357077determine whether the volume of sample fluid provided to the lysis chamber 145 is sufficient for analysis.
[0031] The instrument 150 includes a pump 131 that may pressurize various fluidic channels and chambers of the cartridge 100 (when the cartridge 100 is inserted into the instrument 150) to cause fluid to move through the cartridge 100. For example, the pump 131 may pressurize the first fluid chamber 143 causing sample fluid therein to flow into the fluidic channel 147 toward the lysis chamber 145. The instrument 150 may also include various sensors configured to detect fluid in the cartridge 100. For example, as shown in FIG. 1, the instrument 150 includes a first fluid detection sensor 135 (e.g., an upstream fluid detection sensor) positioned to detect fluid at a first detection location 149 in the fluidic channel 147 (e.g., an upstream fluid detection location) and a second fluid detection sensor 137 (e.g., a downstream fluid detection sensor) positioned to detect fluid at a second detection location 151 in the fluidic channel 147 (e.g., a downstream fluid detection location) downstream of the first detection location 149. Thus, as the pump 131 pressurizes the first fluid chamber 143 to move fluid into and through the fluidic channel 147 the first fluid detection sensor 135 may detect the fluid first, and then the second fluid detection sensor 137 may detect fluid as it travels downstream toward the lysis chamber 145. The volume of the fluidic channel 147 between the first detection location 149 and the second detection location 151 may exceed a threshold volume of sample fluid for analysis. Thus, if the sample fills the entirety of the fluidic channel 147 between the first detection location 149 and the second detection location 151, the sample may have sufficient volume for analysis. Said another way, the first fluid detection sensor 135 and the second fluid detection sensor 137 may be positioned such that when the sample fluid is detected simultaneously by both sensors 135, 137 as it is moved through the fluidic channel 147, it may be determined that the volume of sample fluid is sufficient for analysis.
[0032] The instrument 150 includes a controller 141 that is communicatively coupled to the pump 131, the first fluid detection sensor 135 and the second fluid detection sensor 137. The controller 141 may include a processor and a memory. The processor may be or include an ASIC, one or more FPGAs, a digital signal processor (DSP), circuits containing one or more processing components, circuitry for supporting a microprocessor, a group of processing components, or other suitable electronic processing components. In some examples, the-8- 4923-4563-8928.1Atty. Dkt. No.: 86357077processor may execute computer code or modules (e.g., executable code, object code, source code, script code, machine code, etc.) stored in the memory to facilitate the activities described herein. The memory may be any volatile or non-volatile computer-readable storage medium capable of storing data or computer code.
[0033] The controller 141 may receive first sensor data from the first fluid detection sensor 135 and second sensor data second fluid detection sensor 137. The controller 141 may determine, based on the first sensor data and the second sensor data, when the sample fluid is detected by the first fluid detection sensor 135 and / or the second fluid detection sensor 137. For example, the controller 141 may determine, based on the first sensor data and the second sensor data, that the sample fluid is detected simultaneously by the first fluid detection sensor 135 and the second fluid detection sensor 137. Based on determining that the sample fluid is simultaneously detected by the first fluid detection sensor 135 and the second fluid detection sensor 137, the controller 141 may cause the pump to move the sample fluid into the lysis chamber 145.
[0034] For example, in some implementations, the controller 141 may control the pump 131 to pressurize the first fluid chamber 143 and move the sample fluid through the fluidic channel 147. The controller 141 may determine, based on the second sensor data, that the second fluid detection sensor 137 detects the sample fluid at the second detection location 151 and may cause the pump to stop pressurizing the first fluid chamber 143, stopping the flow of sample fluid at the second detection location 151. Then, based on determining that the fluid is detected simultaneously by the first fluid detection sensor 135 and the second fluid detection sensor 137, the controller 141 may cause the pump 131 to move the sample fluid into the lysis chamber 145. In another example, the controller 141 need not cause the pump 131 to stop the flow of fluid unless the sample is not detected at the first fluid detection sensor 135 and the second fluid detection sensor 137 simultaneously. However, if when the sample fluid is first detected at the second fluid detection sensor 137, the sample fluid is not also detected at the first fluid detection sensor 135, the controller 141 may cause the pump 131 to stop the flow of sample fluid at least until further processes are conducted.-9- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0035] The instrument 150 includes a sonicator 133, which may be configured to agitate fluid in the lysis chamber 145 when the cartridge 100 is inserted into the instrument 150. For example, the sonicator 133 may include an ultrasonic horn that aligns with and generates ultrasonic waves in the lysis chamber 145. In some examples, the sonicator 133 may lyse cells in a biological sample in the lysis chamber 145. For example, the ultrasonic waves generated by the ultrasonic horn may cause lysis of the cells. The controller 141 may be communicatively coupled and configured to operate the sonicator 133. For example, after (e.g., based, on, responsive to, etc.) causing the pump 131 to move the sample fluid into the lysis chamber 145, the controller 141 may cause the sonicator 133 to agitate and lyse cells in the sample fluid in the lysis chamber 145 using ultrasonic energy For example, the sonicator 133 may lyse biological cells in the sample fluid to release nucleic acids for downstream analysis of the sample fluid. If the sample fluid contains biological cells, agitating the sample fluid may cause lysis of some or all of the cells. The controller 141 may then cause the sample fluid to be moved to different regions within the cartridge 100 for downstream processing and analysis. As shown in FIG. 1, the instrument 150 includes a user interface 153, which may be communicatively coupled to the controller 141. The user interface 153 may include a display screen allowing the controller 141 to send messages to a user of the system 100 A. The user interface 153 may include a user input device (e.g., a touchscreen, a keyboard, a mouse, buttons, switches, etc.) to allow the user to input instructions into the controller 141 to control operation of the instrument 150. In some examples, the user interface 153 may be a component of a different device that is communicatively coupled to the controller 141, for example, a smartphone, a laptop computer, a desktop computer, a tablet computer, or any other computing device.
[0036] Referring now to FIG. 2, a diagnostic system 100B, including the cartridge 100 and the instrument 150 is shown, according to an example. The cartridge 100 and the instrument 150 may include the same or similar elements as the elements found in the cartridge and instrument of the system 100 A.
[0037] The system 100B may be configured to detect a nucleic acid of interest. In some examples, the cartridge 100 of the diagnostic system may include a series of zones or chambers that may be defined as cavities. The zones / chambers / cavities may be interconnected via a-10- 4923-4563-8928.1Atty. Dkt. No.: 86357077plurality of channels. The series of cavities / chambers can be individually loaded with reagents. The cavities / chambers can be loaded with the same or with different types of reagents. Loading the cavities / chambers with different types of reagents can permit a multi-step reaction. The reagents / reactants can be disposed in the chambers or blister devices, as will be described herein.
[0038] As shown in FIG. 2, the cartridge 100 includes a first zone 104 (an extraction zone) including the lysis chamber 145, which includes reagents 125, and hybridization chamber 114ba hybridization chamber 114b having magnetic particles 116 and reagents 125. The cartridge 100 includes a second zone 108 (a detection zone) including a detection chamber 120 having a heating element 122. The cartridge 100 includes the first fluid chamber 143, which may be referred to as the sample input chamber 143. It should be understood that the cartridge 100 may include any number of zones. In various examples, each zone is configured to perform or is associated with certain actions. For example, the first zone 104 may be an extraction zone including the lysis chamber 145 and the hybridization chamber 114b, and the second zone 108 may be a detection zone. Further, each zone may include chambers. For example, the first zone 104 may be an extraction zone including extraction chambers 114, and the second zone 108 may be a detection zone including detection chambers 120. The instrument 150 includes a lysis system 152 (e.g., including the sonicator 133), a magnetic field generator 156, a cartridgecontact heater 158, electrical components 160, an optical unit 162, the controller 141, the user interface 153, the pump 131, and sensors, including the first fluid detection sensor 135 and the second fluid detection sensor 137.
[0039] Fluid within the cartridge 100 may move through a plurality of fluidic channels including the fluidic channel 147 coupling the first fluid chamber 143 to the lysis chamber 145. The channels may be fluidly coupled via a plurality of fluidic junctions. Transport of fluid through the cartridge 100 may be moderated by a plurality of valves (e.g., shown in further detail in FIG. 5). For example, the cartridge 100 may include a plurality of pinch valves, membrane valves, etc. configured to selectively permit and restrict flow through the fluidic channels. For example, when a valve is closed, fluid movement may be restricted or blocked. The fluidic channels may permit fluid flow from one of the plurality of zones and / or chambers to another zone and / or chamber. For example, fluid may flow from the extraction zone or an-11- 4923-4563-8928.1Atty. Dkt. No.: 86357077extraction chamber to a detection zone or detection chambers. The instrument 150 includes the pump 131 to interface with the cartridge 100, specifically the fluid channels of the cartridge 100, to pump air to move air and the fluid through the channels. In various examples, a pressure differential across each valve opening can be applied to transport fluid in and out of each of the plurality of zones, each of the plurality of chambers, each blister device, etc.
[0040] The lysis chamber 145 may house a lysing of the biological sample to release nucleic acids of interest from the biological sample. The lysis chamber 145 may be a fluidic structure with an open cavity or void to define a chamber that could be filled with the biological sample comprising the nucleic acids of interest. The lysis chamber 145 may be configured to house a lysis reaction. For example, a biological sample may enter the lysis chamber 145 and may be lysed, for example by sonication, thermal lysis, thermal sonication, or another lysing method. The lysis reaction may damage the content of the biological sample to release nucleic acids from the biological sample. The lysis reaction performed in the lysis chamber 145 may cause the nucleic acids of interest to be released from the biological sample. The lysis reaction may disrupt, or lyse, cells, and / or tissue samples.
[0041] The cartridge 100 may also include reagents 125. The reagents 125 may be located in at least one of the extraction chambers. For example, as shown in FIG. 2, the lysis chamber 145 and the hybridization chamber 114b include reagents 125, however, it should be understood that the reagents 125 may be stored in any chamber or zone and / or multiple chambers or zones of the cartridge 100. In various examples, the cartridge 100 may include only one reagent in only one chamber (e.g., the detection chamber 120). In various other examples, no reagent 125 may be stored in the lysis chamber 145 or the hybridization chamber 114b , and the reagents 125 may be stored elsewhere in the cartridge 100. For example, the reagents may reside in any extraction or detection chambers but may be stored elsewhere instead.
[0042] The reagents 125 may be or include liquid reagents 125 and / or dry reagents 125. The reagents 125 may be used in lysing, hybridization, washing, amplification, and / or detection of the nucleic acids of interest. The reagents 125 may also be or include a dry reagent storing an internal positive control (IPC) organism. The reagents 125 may be or include a master mix-12- 4923-4563-8928.1Atty. Dkt. No.: 86357077reagent. The master mix (MM) reagent may be or include a master mix lyophilized (“lyo”) bead of functionalized paramagnetic particles (e.g., magnetic bead (MB) lyo particles). The master mix reagent may be used during amplification for reverse transcription and / or amplification and real-time detection of the nucleic acids of interest.
[0043] In various examples, liquid reagents 125 may be stored in blister devices of the cartridge 100. For example, liquid reagents (e.g., wash buffer, system composition) may be stored in a metal-lined blister device that may be punctured to release the reagents 125. The reagents 125 may be located in at least one of the lysis chamber 145 or the hybridization chamber 114b or at least one of the detection chambers 120.
[0044] In various examples, dry reagents 125 may be stored as lyophilized (e.g., freeze-dried) pellets or cakes, air-dried pellets or cakes, and / or sealed with a plastic plug or film. For example, a dry reagent may be an enzyme used for DNA or RNA elongation during amplification. The dry reagent can be or include master mix or a PCR mixture. The dry reagent 125 may be stored as a pellet. Dry reagents may be dissolved in order to be properly utilized. In various examples, a device may push against a piston to push a liquid out of a blister device to a location of a pellet to dissolve the pellet. The dissolved pellet may then be transported to a desired location (e.g., the detection chamber 120).
[0045] In various examples, the biological sample can be lysed by a lysis system 152, which may be located within the instrument 150. In various examples, the lysate can be lysed by a plurality of lysing techniques, such as a combination of the lysis system 152, mechanical agitation, an external heat source, ultrasonic agitation, impellers, and / or ceramic or glass beads. In various examples, the lysis system 152 may include the sonicator 133 to interface with the lysis chamber 145. The sonicator may be used to agitate fluid in the lysis chamber 145 and to lyse cells in a biological sample. The sonicator may also be referred to as a “sonotrode.”
[0046] The hybridization chamber 114b may include a plurality of magnetic particles 116. The plurality of magnetic particles 116 may include capture oligonucleotides that may be complementary to the nucleic acids of interest. The capture oligonucleotides may be complementary to the nucleic acids of interest because the capture oligonucleotides may be configured and / or selected to bind specifically to (e.g., and only to) the nucleic acids of interest.-13- 4923-4563-8928.1Atty. Dkt. No.: 86357077The hybridization chamber 114b may receive, from the lysis chamber 145, the nucleic acids released from the lysed biological sample. In the hybridization chamber 114b, the nucleic acids may be hybridized. For example, in the hybridization chamber 114b, the nucleic acids of interest may be hybridized with at least one capture oligonucleotide attached to magnetic particles 116 of the plurality of magnetic particles.
[0047] In various examples, the cartridge 100 may include a plurality of hybridization chambers 114b. For example, the cartridge 100 may include two hybridization chambers 114b. The lysate may be moved from the first hybridization chamber 114b to the second hybridization chamber 114b to fully mix and hybridize the nucleic acids of interest.
[0048] The term “hybridize” as used herein refers to a process where two substantially complementary nucleic acid strands (at least about 65% complementary over a stretch of at least 14 to 25 nucleotides, at least about 75%, or at least about 90% complementary) anneal to each other under appropriately stringent conditions to form a duplex or heteroduplex through formation of hydrogen bonds between complementary base pairs. For example, hybridization may refer to the formation of a double strand from two single strands, which can each include a nucleic acid and / or a capture oligonucleotide. The capture oligonucleotide may be, for example a DNA or RNA sequence having a complementary sequence to the nucleic acid of interest. Under suitable reaction conditions, the hybridization generally leads to the lowest possible energy state that can be achieved by the combination of the two single strands. In other words, under suitable conditions, the two single strands may bind to each other in such a way that, with respect to the sequences of the two single strands, the greatest possible complementarity (i.e., specificity) is produced.
[0049] In some examples, hybridizations are conducted with probe-length nucleic acid molecules, 15-100 nucleotides in length, or 18-50 nucleotides in length. Hybridization and the strength of hybridization (i.e., the strength of the association between the nucleic acids) is influenced by such factors as the degree of complementarity between the nucleic acids, stringency of the conditions involved, and the thermal melting point I of the formed hybrid. The stringency of hybridization conditions may be estimated and / or adjusted such that sequences having at least a desired level of complementarity will stably hybridize, while those-14- 4923-4563-8928.1Atty. Dkt. No.: 86357077having lower complementarity will not. In some examples, specific hybridization occurs under stringent hybridization conditions. An oligonucleotide or polynucleotide (e.g., a probe or a capture oligonucleotide) that is specific for a target nucleic acid will “hybridize” to the target nucleic acid under suitable conditions.
[0050] The cartridge 100 may include a plurality of the magnetic particles 116. Specifically, the hybridization chamber 114b may include a plurality of the magnetic particles 116. The magnetic particles 116 may also be referred to as “magnetic beads,” “beads,” and / or “particles” As used herein, “magnetic beads” or “magnetic particles” refer to microparticles that have ferromagnetic or paramagnetic properties. For example, the magnetic particles 116 may be or include (strept)avidin with biotinylated oligonucleotides, covalently bound oligonucleotides, polymer beads with embedded iron particles, etc. The size of the microparticles is optionally in a range from approximately 10 nm to approximately 2 mm, optionally in a range from 100 nm to 1 mm, optionally in a range from 500 nm to 50 pm. The shape of the microparticles can be freely selected and can, for example, be spherical, cube-shaped, cuboid, or ellipsoidal. The magnetic particles with ferromagnetic properties are optionally formed from at least one of the following materials or contain at least one of the following materials: iron, nickel, cobalt, AlNiCo, SmCo, Nd2Fei4B, NieoFe2o (“Permalloy”), and / or NiFeCo alloys. Optionally, the magnetic particles with paramagnetic properties are made of at least one of the following materials formed or contain at least one of the following materials: alkaline earth metals, alkali metals, and / or rare earths. Alternatively, a magnetic microparticle can be formed from a nonmagnetic material such as glass and / or silicate, with magnetic substances being embedded therein. For example, such a microparticle can have a core made of magnetic materials. The magnetic microparticles are optionally provided with at least one coating in order to enable or promote functionalization with nucleic acids, in particular with extraction nucleic acids and / or capture oligonucleotides. Optionally, at least one extraction nucleic acid and / or one capture oligonucleotides and a maximum of 1012extraction nucleic acids and / or capture oligonucleotides are functionalized on a microparticle. Optionally, an areal density of extraction nucleic acids and / or capture oligonucleotides that are functionalized on the surface of a magnetic microparticle is in a range from 0.0001 to 1 per square nanometer. The microparticles can optionally have a coating which enables and / or facilitates functionalization-15- 4923-4563-8928.1Atty. Dkt. No.: 86357077with capture oligonucleotides. For example, the surface of the magnetic microparticles can be at least partially functionalized with streptavidin.
[0051] The magnetic particles 116 may have a nucleic acid attached. Specifically, the attached nucleic acids may be attached to the magnetic particles 116 by capture oligonucleotides that are attached to the magnetic particles 116. The capture oligonucleotides attached to the magnetic particles 116 are selected to be complementary in part or in full to the nucleic acids of interest. In the hybridization chamber 114b, the nucleic acids from the lysis chamber 145 may be hybridized to the capture oligonucleotides attached to the magnetic particles 116. In some examples, the magnetic particles 116 comprise capture oligonucleotides that bind to the nucleic acids of interest (e.g., from the lysis chamber 145). In various examples, the capture oligonucleotides may be the same or different from each other. For example, a first capture oligonucleotides attached to a first magnetic particle 116 may have a first sequence, and a second capture oligonucleotides attached to a second magnetic particle 116 may have a second sequence.
[0052] In various examples, the cartridge 100 includes a plurality of hybridization chambers 114b. During hybridization, the fluid containing the biological sample may move between the plurality of hybridization chambers to allow for mixing (e.g., partial mixing, complete mixing, etc.) of the solution or fluid during hybridization. Mixing the fluid may occur to distribute the magnetic particles 116 throughout the fluid (e.g., the lysate). Mixing may additionally or alternatively occur using ultrasonic mixing, acoustic mixing, impellers, mechanical agitation, diffusion, and / or channel geometry, such as turns, ridges, and / or mini chambers.
[0053] During hybridization, the fluid may also be heated. The solution may be heated in a variety of ways, such as using an external contact heat source, ultrasonic energy, acoustic energy, and / or infrared radiation (IR).
[0054] The second zone 108 may be, in various examples, a detection zone including detection chambers 120. In various examples, a different zone may include the detection chambers. The detection chambers 120 need not be a part of or associated with a zone.-16- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0055] The cartridge 100 may include detection chambers 120. The detection chambers 120 may be configured to amplify and detect the nucleic acids of interest that have been lysed (e.g., from the biological sample) and hybridized (e.g., to the functionalized magnetic particles 116). Thus, in various examples, at least one of the detection chambers 120 is an amplification chamber. The detection chambers 120 may amplify the nucleic acid of interest through, for example, pulse controlled amplification (PCA).
[0056] As used herein, the terms “amplify” or “amplification” with respect to nucleic acid sequences, refer to methods that increase the representation of a population of nucleic acid sequences in a sample. Copies of a particular target nucleic acid sequence generated in vitro in an amplification reaction may be referred to as “amplicons” or “amplification products.” In various examples, amplification products may refer to any products amplified during an amplification reaction. For example, amplification products may include nucleic acids, unquenched fluorophores generated during each replication cycle of the amplification reaction, etc. Amplification may be exponential or linear. A target nucleic acid may be DNA (such as, for example, genomic DNA and complementary DNA (cDNA) or RNA). While the methods described hereinafter relate to amplification using polymerase chain reaction (PCR), numerous other methods such as isothermal methods, rolling circle methods, etc., may be used either in place of, or together with, PCR methods. In at least one of the detection chambers 120, a lyophilized master mix reagent may be stored. The master mix reagent may refer to a reagent used during an amplification reaction, such as a PCR or PCA reaction.
[0057] In various examples, the amplification reactions may utilize primers to perform amplification of the nucleic acids. Primers are short, artificial, single-stranded segments of nucleic acid (e.g., DNA) that are designed to be complementary to the beginning and / or end of the target sequence that will be amplified. The primer sequences may be shorter than the one of the capture oligonucleotides. For example, a primer may contain about 10 to 25 nucleotides.
[0058] Primers may perform specific functions during amplification. For example, during the amplification / elongation step of the PCR, the primers may bind to both ends of the nucleic acid of interest (e.g., the DNA sequence of interest), thus bookending the sequence of interest that need to be amplified. Enzymes (e.g., DNA polymerase) may then copy the part of the target-17- 4923-4563-8928.1Atty. Dkt. No.: 86357077oligonucleotide sequence that falls between the primers, selectively amplifying the sequence of interest. In some examples, the capture oligonucleotides described above may also be used as primers during amplification. In other examples, the primers may be oligonucleotides different than the capture oligonucleotides. In some examples, the primers may be forward and / or reverse primers. Forward and reverse primers may denote a direction of elongation during the polymerization by the polymerase enzyme. The primers may be used during the amplification / elongation step of the reaction and may comprise part of the master mix composition described herein.
[0059] The detection chamber 120 may include a heating element 122. For example, a detection zone of a plurality of zones may include detection chambers 120 having heating elements 122. Each detection chamber 120 may include a heating element 122. In various examples, at least one of the detection chambers may be an amplification chamber. Further, the heating element of the amplification chamber may be a foil configured to interact with the electrical components 160 of the instrument 150. The electrical components 160 may provide an electrical connection between the instrument 150 and the detection chamber 120, thus providing heat modulation to the detection chamber 120 to amplify the nucleic acids of interest that have been hybridized to the capture oligonucleotides of the plurality of magnetic particles. Specifically, the electrical connection may activate the heating elements 122 of each of the detection chambers 120.
[0060] The heating element 122 may be positioned or located at a side portion (e.g., only a single side, such as a single wall of the detection chamber 120) of the detection chamber 120. The heating element 122 may include a plurality of layers comprising at least a foil. The heating element 122 may be attached to an adhesive and / or a heat spreader or conductor. The heating element 122 may be or include, in various examples, a continuous, structured, or shaped metal foil, metal wires, a conductor and / or resistor layer deposited and / or plated, and / or backed by a heat spreader. The heating element 122 may be configured to heat the detection chamber 120 during the PC A process. The heating element 122 may be, for example, a foil to locally heat a portion of the detection chamber 120. For example, a heating element 122 of the amplification chamber (e.g., the detection chamber 120) may be or include a foil to interact with electrical components 160 of the instrument 150 provide an electrical connection to-18- 4923-4563-8928.1Atty. Dkt. No.: 86357077activate the heating elements 122 of each of the detection chambers 120. The heating element 122 may provide heat modulation to amplify the nucleic acids of interest that have been hybridized to the at least one capture oligonucleotide attached to magnetic particles 116 of the plurality of magnetic particles in the hybridization chamber 114b.
[0061] During the PCA reaction occurring in the detection chamber 120, the heating element 122 may be used to heat a portion of the volume of the detection chamber 120. For example, only a portion of the detection chamber 120 proximate the heating element 122 may be heated. The heating element 122 may be heated by a short electric pulse or other process. Each pulse may be short (e.g., between about 10 and about 1200 microseconds) and each pulse may be delivered quickly in succession. In some examples, the heating time in at least one amplification cycle, in at least 10, at least 20, at least 40, at least 80, or in at least 160 amplification cycles is more than 1 nanosecond, more than 5 nanoseconds, or more than 10 nanoseconds and less than 100 milliseconds, less than 10 milliseconds, less than 1 millisecond, less than 300 microseconds, less than 100 microseconds, less than 50 microseconds, less than 30 microseconds, less than 10 microseconds, less than 5 microseconds, or less than 1.5 microseconds.
[0062] Due to a resistance of the foil and the rapid pulsing, heat created by the pulses may be local (e.g., the pulses heat only a small portion of the detection chamber 120 surrounding the heating element). In various examples, the pulses may be generated by an energy or power source (e.g., energy source 166). When the pulses are ceased or removed, the portion of the detection chamber 120 that has been heated by the pulses may return to the same temperature as the rest of the detection chamber not proximate the heating element 122. As such, denaturation of the nucleic acids or other molecules occurs in a small volume near the heating element 122.
[0063] Denaturation of a nucleic acid may include separate it into its two single strands. For example, the original can be separated from the complement during denaturing. Denaturing may also be referred to as melting. The denaturing of the nucleic acid double strand may be thermally induced. For example, at least a part of the nucleic acid double strand or the whole double strand is exposed to a temperature, described as a denaturing temperature, which causes-19- 4923-4563-8928.1Atty. Dkt. No.: 86357077or at least encourages a separation of the nucleic acid double strands. The denaturing temperature may not be a fixed temperature but may be a temperature interval, within which the temperature during denaturing varies. The denaturing temperature may be selected to be so high that nucleic acid double strands can be separated and / or so low that a DNA polymerase, which may aid in denaturation, is not substantially damaged. In some examples, a denaturation temperature may be between 90 and 100 degrees Celsius. For example, a denaturing temperature may be 95 degrees Celsius.
[0064] This heating process may cause the overall temperature of the detection chamber 120 to be isothermal (e.g., no change, substantially no change, or minimal change in temperature is seen during heating for the PC A reaction), because the heated portion of the detection chamber 120 is small enough that an overall temperature change is not seen by the detection chamber 120. In various implementations, heat flow in and out of the detection chamber 120 may be present. The heating element 122 may cause a slight (e.g., less than 1 degree Celsius) increase in the overall temperature of the detection chamber 120. For example, heat may be unable to be transferred out of the detection chamber 120, and each pulse generated by the heating element 122 may add heat to the chamber. However, the pulse may heat a small enough volume of the detection chamber 120 relative to the total volume of the detection chamber 120 such that the volume heated by the heating element 122 can rapidly return to a setpoint temperature of the detection chamber 120.
[0065] Referring still to FIG. 2, the instrument 150 is shown, according to example. The diagnostic system 100B may include the instrument 150 to interface with (e.g., connect to) the cartridge 100. The cartridge 100 may be inserted into the instrument 150 to perform the processes described herein. In various examples, the cartridge 100 may be a single use cartridge. For example, one cartridge may be used one time to detect the presence of nucleic acids in one biological sample.
[0066] The instrument 150 may include the lysis system 152. The lysis system 152 may interface the lysis chamber 145. The lysis system 152 may include the sonicator 133. The sonicator 133 may interface with the lysis chamber 145. The sonicator 133 may include an ultrasonic horn that transmits ultrasonic waves generated by the sonicator 133 into a sample in-20- 4923-4563-8928.1Atty. Dkt. No.: 86357077the lysis chamber 145 to agitate the fluid in the lysis chamber 145. The lysis system 152 may be utilized when the biological sample enters the lysis chamber 145 of the cartridge 100 to lyse the sample and release the nucleic acids of interest. The lysis system 152 may be coupled to or positioned proximate the lysis chamber 145 when the cartridge 100 is inserted into the instrument 150. For example, the ultrasonic horn may be positioned immediately adjacent the lysis chamber 145 such that ultrasonic waves transmitted by the ultrasonic horn may propagate through a sample in the lysis chamber 145.
[0067] In various examples, the lysis system 152 may be a lysis system comprising sonication (e.g., use of ultrasonic energy), thermal lysis, and / or thermal sonication system. In some examples, the lysis system 152 may include a heating system. In examples where the lysis system 152 includes a heating system, the lysis system 152 may heat the lysis chamber 145 to a target temperature (e.g., between 35 and 100 degrees Celsius), such as by heating the heating element of the lysis chamber 145 to the target temperature, to release the desired molecule of interest (e.g., nucleic acid) from the biological sample. For example, the lysis system 152 may heat the lysis chamber 145 to 95 degrees Celsius. In some examples, the sonicator 133 may generate heat in a sample in the lysis chamber 145 using ultrasonic waves.
[0068] In some examples, the lysis system 152 is programmable. Thus, a user may be able to control, set, determine, etc. lysing protocol parameters (e.g., using the controller 141), such as the sample volume, sonication power level, acoustic frequency, and lysing duration. The lysis system 152 may also provide a cooling feature, enabled by a heat exchanging sub-assembly, which may prevent the biological sample from exceeding a maximum set temperature during operation. The lysis system 152 is discussed below in further detail with respect to FIG. 4.
[0069] The instrument 150 may include a magnetic field generator 156 to generate a magnetic field. The magnetic field may be used to dock the plurality of magnetic particles 116 to at least one zone of the plurality of zones of the cartridge 100. In various examples, the magnetic field generator 156 is a magnet (e.g., a permanent magnet). The magnetic field generator 156 may be positioned at or proximate the detection chamber 120. The magnetic field generator may be configured to generate a magnetic field such that the magnetic particles 116 that are hybridized with the nucleic acid of interest and / or the capture oligonucleotides are separated-21- 4923-4563-8928.1Atty. Dkt. No.: 86357077from the lysate solution such that the PCA reaction can occur. The magnetic field generator 156 may be a current carrying conductor or other device that may be powered on or activated such that electric charges being moving to create the magnetic field. In various examples, the instrument 150 may be activated or powered on to activate the magnetic field generator.
[0070] In some examples, the magnetic field generator 156 is configured to generate a variable magnetic field in such a manner that acts on at least a part of the magnetic particles 116 present in the detection chamber and that are linked to the nucleic acid of interest.
[0071] In another example, the variable magnetic field may act on at least a part of the magnetic particles 116 present in the detection chamber 120 in such a manner that the magnetic particles 116 attach to the local heating element 122. Further, the variable magnetic field may be configured to act on the magnetic particles 116 attached to the local heating element 122 in such a manner that they leave the local heating element 122 and are suspended in a reaction solution. This may allow the magnetic microparticles 116 to be optionally attached to and / or repelled from the local heating element 122 multiple times, allowing them to hybridize with additional target nucleic acids in the reaction solution.
[0072] The magnet or plurality of magnets may be or include a permanent magnet and / or an electromagnet that can be changed in position and / or orientation relative to the reaction container. For example, when using a permanent magnet, the magnetic field may be changed by changing an orientation of the permanent magnet to the detection chamber 120 and / or a distance of the permanent magnet from the detection chamber 120. The direction of the magnetic field can also be changed, for example, by reversing the permanent magnet relative to the reaction container such that, for example, the side of the permanent magnet facing the reaction container changes from the magnetic north pole to the south pole of the permanent magnet or vice versa. When using an electromagnet, for example, the variable magnetic field can be changed by changing the current flow, in such a manner as the current intensity and / or the direction of the current flow. For example, the electromagnet may comprise solenoid coils and may include a ferromagnetic core. The magnet may be formed on a side of the local heating element 122 facing away from the detection chamber 120. This may offer the advantage that the permanent magnet in this arrangement makes it particularly effective and easy to attract the-22- 4923-4563-8928.1Atty. Dkt. No.: 86357077magnetic microparticles 116 to the local heating element. Alternatively or additionally, the magnets may be changed in position relative to the detection chamber to provide a variable magnetic field in the reaction solution. Alternatively or additionally, several magnets with different polarity can be brought to the detection chamber to achieve a variable magnetic field in the detection chamber.
[0073] The instrument 150 may include cartridge-contact heaters 158. The cartridge-contact heater 158 may be a heater configured to heat components, zones, etc. of the cartridge 100. For example, the cartridge-contact heater 158 may heat the lysis chamber 145 during lysing of the biological sample with the system composition and the internal positive control (IPC). The cartridge-contact heater 158 may also be used to heat the lysate during hybridization. In various examples, the heating elements 122 may be or include the cartridge-contact heater 158. The cartridge-contact heater 158 may interface with a heat spreader 510. The heat spreader may be a conduit of the cartridge contact heater 158 and may facilitate heat transfer from the cartridgecontact heater 158 to the detection chambers 120.
[0074] The instrument 150 may include electrical components 160. The electrical components 160 may provide an electrical connection between the instrument 150 and zones, chambers, components, etc. of the cartridge 100. For example, the electrical components 160 may provide an electrical connection between the instrument 150 and the cartridge 100 to activate the heating elements 122 of each of the detection chambers 120. An interaction of the detection chamber 120 and the electrical components 160, via an electrical connection, may provide heat modulation to amplify the nucleic acids of interest that have been hybridized to the capture oligonucleotides of the plurality of magnetic particles 116. The electrical components may provide a connection to the heating element 122 in the detection chamber.
[0075] The instrument 150 may include an optical unit 162. The optical unit 162 may be coupled with at least one of the detection chambers. The optical unit 162 may be configured to detect a presence, absence, amount, etc. of the nucleic acid of interest after amplification has been performed. In various examples, the optical unit 162 is to detect a plurality of amplification products indicative of a presence, absence, or amount of the amplified nucleic-23- 4923-4563-8928.1Atty. Dkt. No.: 86357077acids of interest. The optical unit 162 may detect the nucleic acid via a label bound to the nucleic acid of interest during amplification.
[0076] In various examples, the cartridge 100 may include a transparent window in at least one detection chamber (e.g., the detection chamber 120) of the detection chambers to allow the optical unit 162 to detect a plurality of amplification products indicative of a presence, absence, or amount of the plurality of amplified nucleic acids of interest. In various examples, the detection chamber 120 may include the transparent window. A transparent window may permit light from the optical unit 162 to pass through the cartridge 100 and / or detection chamber 120 so that light can enter the detection chamber 120 and detect the amplification products indicative of a presence, absence, or amount of the plurality of amplified nucleic acids of interest.
[0077] In some examples, detection by the optical unit 162 may be performed in the detection chamber 120 and may be done using a label bound to the nucleic of interest. Specifically, the optical unit 162 may be used for fluorescence sensing. For example, fluorophores may be generated during each replication cycle of the amplification reaction. Fluorophores may be used to infer the presence or amount of nucleic acids in the detection chamber 120. In PCA (and / or PCR), fluorophores may be attached to capture oligonucleotides and a quencher molecule prior to amplification. This compound molecule may be included in the master mix reagent. In the proximity of the quencher, the compound molecule may not fluoresce. However, during PCA (and / or PCR), the compound molecule may anneal or attach to a portion of the target nucleic acids. A polymerase enzyme, while constructing a double stranded amplicon, may release the fluorophore to separate the fluorophore from the quencher and allow the fluorophore to fluoresce.
[0078] In some examples, the detection step may include detecting the fluorophore via a sensor located within the optical unit 162. For example, the optical unit 162 and any sensors located within may be positioned in the instrument 150 such that the optical unit 162 and / or the sensors interface with and / or are located proximate the detection chamber 120 when the cartridge 100 is inserted into the instrument 150. In some examples, the sensor may be a-24- 4923-4563-8928.1Atty. Dkt. No.: 86357077fluorescence sensor coupled to the optical unit 162 and configured to detect the fluorescence from the zones of the cartridge 100.
[0079] In some examples, the optical unit 162 may detect the nucleic acid of interest by detecting an intensity of fluorescent probes in the detection chamber 120. The detection chamber 120 may be configured to transmit fluorescent emission to a sensor within the optical unit 162 located in the instrument. For example, during amplification, fluorophores may be released (e.g., using Taqman probes) into solution during elongation for specific detection of amplified products. The optical unit 162 may detect the fluorophores that may be indicative of the presence, absence, amount, etc. of the nucleic acid of interest.
[0080] Referring now to FIG. 3, a method 200 for detecting a presence, absence, or amount of a nucleic acid of interest is shown, according to an example. At process 202, a fluid comprising a biological sample is inserted into a cartridge (e.g., the cartridge 100). In various examples, the biological sample may include the nucleic acid of interest. In various examples, the biological sample may contain another non-nucleic acid molecule of interest. In various examples, the nucleic acid of interest may be a DNA strand and / or an RNA strand. The cartridge may include a plurality of zones as discussed above with respect to FIG. 2. Each zone of the plurality of zones may be in fluid communication with each other. For example, the plurality of zones may be or include an extraction zone and / or a detection zone in fluid communication with one another. The extraction zone may include the lysis chamber 145 and the hybridization chamber 114b and the detection zone may include detection chambers 120. In various examples, each detection chamber 120 may include heating elements 122. The cartridge may further include reagents 125 and a plurality of magnetic particles 116.
[0081] In various examples, prior to lysing the biological sample at process 204, a system composition (e.g., the system composition 106) may be added to the biological sample. The system composition may comprise water, a salt, and a surfactant. The system composition may be used during the lysing step occurring at process 204.
[0082] At process 204, the biological sample is lysed into at least one of the extraction chambers (e.g., lysis chamber 145). Lysing the biological sample may release the nucleic acids of interest from the biological sample. In various examples, the biological sample may be lysed -25- 4923-4563-8928.1Atty. Dkt. No.: 86357077by, for example, sonication (e.g., using the sonicator 133), heating, mechanical agitation, etc. In various examples, the biological sample may be mixed with an IPC and / or a system composition 106 to form a lysate, which may then be lysed to release the nucleic acids of interest from the biological sample. For example, the method can include lysing in the device a biological sample can include the nucleic acids of interest to release the nucleic acids of interest from the biological sample. For example, the biological sample is lysed by sonication, thermal lysis, and / or thermal sonication.
[0083] At process 206, the nucleic acids of interest are hybridized in the at least one hybridization chamber 114b. The nucleic acids of interest may be hybridized to or with at least one capture oligonucleotide attached to magnetic particles 116 of the plurality of magnetic particles 116. For example, the hybridization chamber 114b may include a plurality of magnetic particles 116. The magnetic particles 116 may include attached capture oligonucleotides. The nucleic acids of interest may be hybridized to the capture oligonucleotides.
[0084] At process 208, the nucleic acids of interest with the at least one capture oligonucleotide attached to the magnetic particles 116 may be transported to at least one detection chamber 120 of the detection chambers 120. The nucleic acids of interest may be transported, for example, via channels within the cartridge 100.
[0085] At process 210, the magnetic particles 116 may be trapped into close proximity of the heating elements 122 of the at least one detection chamber 120. In various examples, the detection chamber 120 may be locally heated at or around the heating element 122 to perform amplification. As such, the magnetic particles containing the nucleic acids of interest may be trapped near the heating element 122 so that the nucleic acids of interest can undergo the amplification reaction to be identified by the optical unit 162.
[0086] At process 212, a plurality of amplification reagents 125 may be delivered to the at least one detection chamber 120. In various examples, the plurality of amplification reagents 125 may include, for example, a lyophilized master mix reagent, an enzyme for use in amplification, etc. The amplification reagents 125 may be located in various locations of the cartridge (e.g., in blister devices) and may be transported to the detection chamber prior to amplification. In -26- 4923-4563-8928.1Atty. Dkt. No.: 86357077various examples, the amplification reagents may be stored as dry or wet reagents. Dry reagents may be dissolved prior to use.
[0087] The method 200 may further include washing or removing, using at least one wash buffer 110, undesired elements from the at least one detection chamber 120. Washing may be performed by introducing the wash buffer 110 into the at least one detection chamber 120. For example, the wash buffer 110 may be released from a blister device and may be transported to the detection chamber 120. A plurality of wash buffers may be used to wash the detection chamber 120.
[0088] At process 214, the nucleic acids of interest may be amplified in at least one of the plurality of zones. The nucleic acids of interest may be amplified via an amplification reaction. The amplification reaction may provide a plurality of the nucleic acids of interest.
[0089] In various examples, amplifying the nucleic acids of interest may be performed in the at least one detection chamber 120 by generating a pulse of current via an electrical connection of an instrument 150. The instrument 150 may receive and interact with the cartridge 100. The pulse of current may modulate a temperature proximate the heating elements 122 of the at least one detection chamber 120 to increase a temperature proximate the heating elements of the at least one detection chamber 120 to between 90 and 110 degrees Celsius. For example, the temperature may be increased to 100 degrees Celsius. In various examples, only a portion of the detection chamber may be heated by the pulses. In various examples, amplification may be performed by a PCA reaction.
[0090] At process 216, a plurality of amplification products indicative of the presence, absence, or amount of the plurality of amplified nucleic acids of interest may be detected. The amplification products may be detected via an optical unit 162 in communication with the at least one detection chamber 120 of the detection chambers 120. For example, during amplification, the plurality of nucleic acids of interest may be tagged, for example, using fluorophores. The optical unit 162 may detect an amount of fluorophores, which may be indicative of a presence, absence, and / or amount of the nucleic acid of interest in the biological sample.-27- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0091] FIG. 4 depicts an example diagnostic system, in accordance with present implementations. As illustrated by way of example in FIG. 4, an example diagnostic system 400 can include a cartridge and an instrument. The cartridge may be the same as or similar to the cartridge 100 of systems 100A-100B. Further, the instrument may be the same as or similar to the instrument 150 of systems 100A-100B.
[0092] The cartridge of the example diagnostic system 400 may include a pump interface 404, a plurality of valves 408a-s, a plurality of frangible seals 410a-h, a liquid sample input chamber 412 (e.g., similar or equivalent to the first fluid chamber 143 of the system 100A of FIG. 1 or 100B of FIG. 2), a sample filter 414, a p-trap 416, an umbrella valve 418, a plurality of bubble traps 420a-d, a system composition blister devices 422, wash buffer blister devices 424a and 424b, a plurality of junctions 426a-d, a sample input (SI) metered section 430, an IPC 431, a lysis chamber 432 (e.g., the lysis chamber 145) including lysing beads 436 and a filter for lysing 438, a PCA buffer 440 (stored in a blister device), a PCA buffer metered section 442, a master mix mixing chamber 444 having a master mix 446 (e.g., a lyophilized PC master mix), a vent membrane 448, a first mixing chamber 450, a second mixing chamber 452 having functionalized paramagnetic particles 454 (e.g., MB lyo particles), and a PCA chamber 456.
[0093] As shown in FIG. 4, the instrument of the diagnostic system 400 may include a pump 402 (e.g., air cylinder pumps, diaphragm pumps, a syringe pump (as shown), etc.), which may be similar or equivalent to the pump 131 of the system 100A of FIG. 1, a plurality of fluid sensors 428a-f (which may include sensors similar or equivalent to first fluid detection sensor 135 and second fluid detection sensor 137 of the system 100 A of FIG. 1) , an external magnet 458, and an external sonicator (similar or equivalent to the sonicator 133 of the system 100 A of FIG. 1) with an ultrasonic horn 434. The elements of the instrument may be positioned such that certain components interface with certain components of the cartridge. For example, FIG.4 indicates locations of fluid sensors 428a-f within the instrument relative to the elements within the cartridge. For example, fluid sensors 428a-f may be disposed within the instrument at various locations corresponding to elements located in the cartridge such that the sensors 428a-f sense fluid motion, movement, etc. within the cartridge at the indicated positions.-28- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0094] Sensor 428a may be similar or equivalent to the first fluid detection sensor 135 and is shown to be located at the first detection location 149 at an inlet of the SI metered section 430, which may be similar or equivalent to the fluidic channel 147. The sensor 428a need not be physically located within the cartridge at the inlet of the SI metered section. Rather, the sensor 428a may be positioned within the instrument (e.g., instrument 150) such that, upon insertion of the cartridge into the instrument, the position of the sensor 428a aligns with the first detection location 149 at the inlet of the SI metered section 430. Sensor 428b may be similar or equivalent to the second fluid detection sensor 137 and is shown to be located at the second detection location 151 at an outlet of the SI metered section 430.
[0095] Further, as stated, the instrument of the diagnostic system 400 may also include a magnet 458 to interface with the PCA chamber 456. The magnet may be positioned within the instrument such that, upon insertion of the cartridge into the instrument, the location of the magnet 458 aligns with the position of the PCA chamber 456 within the cartridge. As discussed above the instrument of the diagnostic system 400 may also include a sonicator (e.g., similar or the same as the sonicator 133) including an ultrasonic horn 434. When the cartridge is inserted into the instrument, the ultrasonic horn 434 may align with the position of the lysis chamber 432 within the cartridge. Thus, when the sonicator is activated, the ultrasonic horn 434 may transmit ultrasonic waves into the lysis chamber 432 to lyse a sample therein.
[0096] In various examples, the lysis chamber 432 may be similar or equivalent to the lysis chamber 145 and the mixing chambers 450 and 452 may be similar to the hybridization chamber 114b and may be collectively referred to as a fluid mixing device 464. The PCA chamber 456 may also be similar or equivalent to the detection chamber 120.
[0097] A user may fill the liquid sample input chamber 412 with a sample liquid. The sample liquid may be a biological sample containing nucleic acids or other molecules of interest. The sample input chamber 412 maybe similar to or the same as the sample input chamber 143. The user may fill the sample input chamber 412 via a pipette, an exact volume pipette, a dropper, syringe injection, etc. The sample input chamber 412 may include fill guides to indicate a fill level. Upon filling the sample input chamber 412, all 408a-s may be open. An umbrella valve 418 may disable the sample input chamber 412 from filling the sample metering circuit (e.g.,-29- 4923-4563-8928.1Atty. Dkt. No.: 86357077the SI metered section 430). In various examples, the umbrella valve 418 may be a type of check valve. For example, the umbrella valve 418 may prevent flow back towards the liquid sample input chamber 412. The umbrella valve 418 may have a sufficient cracking pressure in a forward direction, thereby preventing the fluid in the sample input chamber 412 from reaching the sample metering section 430 from gravity (e.g., a head height pressure). Upon filling the liquid sample input chamber 412, the chamber may be closed. For example, a sample input cover of the cartridge may be closed.
[0098] Upon filling the sample input chamber 412, the sample may be pressurized by the pump 402 through valve 408a. Pressure may be vented through normally open valves 408k, 408n and / or 408o and the vent membrane 448. For example, pressure may be vented through valve 408k and vent channel 445. Thus, the sample may be pushed through the umbrella valve 418, the bubble trap 420a, and into the sample metering channels (e.g., the SI metered section 430, the fluidic channel 147). Fluid flow may be monitored as the liquid moves past an inlet of the SI metered section 430. The sensors 428a and 428b may monitor the fluid flow until the liquid reaches the sample metering outlet sensor 428b. Responsive to the liquid reaching the outlet sensor 428b, flow may be stopped. For example, valves may close to prevent movement of the liquid.
[0099] As discussed above with respect to the fluid detection sensors 135, 137 of FIG. 1, the sensors 428a-428f may detect if a cartridge channel or chamber has liquid or air present. The sensors 428a-428f may track progress of liquid slugs, meter liquid by triggering the halt of flow to control volume of fluid (e.g., sensors 428b, 428c, and 428f), help in reciprocating mixing by triggering when a flow should be reversed (e.g., sensors 428d, 428e, and 428f), and / or help locate the reconstituted master mix reagent in the PC A chamber (e.g., sensors 428c and 428f). For example, after the sample input chamber 412 (or sample input chamber 143) has been pressurized to move sample fluid into the SI metered section 430 (or fluidic channel 147), the upstream sensor 428a (or first fluid detection sensor 135) may detect the sample fluid as it reaches the first detection location 149. The sample fluid may continue to flow through the SI metered section 430 to the second detection location 151, where the sample fluid may be detected by the downstream sensor 428b (or second fluid detection sensor 137).-30- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0100] In various examples, sensors from the instrument 150 may be optical and / or capacitive. Optical sensors may be or include LEDs and photodiodes to detect changes in contrast, color, reflection, etc. in a microfluidic channel or chamber. Capacitive sensors may be or include capacitor plates to detect change in dielectric between liquid and air in a microfluidic channel or chamber.
[0101] Responsive to metering the sample, frangible seals 410a and 410b may be opened. Opening the frangible seals 410a and 410b may enable fluid flow into and out of the system composition blister device 422. The pump 402 may interface with the pump interface 404, which is fluidly coupled to the fluidic channels of the cartridge 100 and fluidly couplable to the pump. The cartridge (e.g., at least a portion of the fluidic channels in the cartridge) may be pressurized by the pump 402 through the pump interface 404 and pinch valve 408b, thus purging the sample from the SI metered section 430. Further, the sample may reconstitute an IPC lyo particle 431, and the sample may fill the lysis chamber 432. Pressure may be vented through pinch valves 408n, 408o, and / or 408k and / or the vent membrane 448 to allow the fluid flow. For example, pressure may be vented through the pinch valve 408k.
[0102] In various examples, the system composition fluid (e.g., system composition 106) may flow through the SI metered section 430 as the blister device 422 empties, pushing the sample out of the SI metered section 430. In various examples, it may be beneficial to fully empty the blister device 422 for improved performance. Air may then be pushed through the blister device 422 (e.g., via syringe pump 402) to fully empty the blister device 422 and purge any remaining system composition fluid from the SI metered section 430 into the lysis chamber 432. Metering sensors (e.g., sensors 428a and 428b) may manage a flow rate through the SI metered section 430 and minimize an amount of air pushed into the lysis chamber 432 from the system composition blister device 422.
[0103] Responsive to emptying the system composition blister device 422, the cartridge 100 may be pressurized through the pump interface 404 and the pinch valve 408d. The lysis chamber 432 may then be pressurized to ensure contact between a lysis chamber film and a lysis chamber heater. In various examples, all valves may be closed to isolate the lysis chamber 432 during lysis. In various examples, lysis may be an ultrasonic lysis. As such, the ultrasonic-31- 4923-4563-8928.1Atty. Dkt. No.: 86357077horn 434 may be pulsed, and a temperature of the lysis chamber 432 may be controller via the horn 434, the heater, and / or a temperature sensor. The ultrasonic pulses may lyse the fluid and mix the sample, the system composition, and the IPC lyo particle 431.
[0104] Responsive to lysing the sample, the cartridge 100 may be pressurized by the pump 402 through the pump interface 404, the pinch valve 408d, and the upstream channel 443. Further the valves 408p, 408o and / or 408n may be opened. This may allow the lysate (e.g., the lysed sample, the system composition, and the IPC lyo material mixture) to be delivered from the lysis chamber 432, out of the lysis chamber outlet 441, through a PCA common line 439 and the PCA chamber 456 into the mixing chamber 450 and / or the mixing chamber 452 (e.g., a hybridization chamber). The entrance of the lysate into the Mixing chamber 450 and / or Mixing chamber 452 may cause the MB lyo particles 454 to be reconstituted. In various examples, all of the lysate is delivered from the lysis chamber 432. Flow may be stopped responsive to a determination that a trailing meniscus of the lysate is detected by a PCA inlet sensor (e.g., the fluid sensor 428c). The PCA chamber 456 may be kept full of fluid to minimize air generation in the chamber, which may disrupt amplification.
[0105] Responsive to the lysate entering the mixing chamber 452, hybridization may occur. For example, the lysate may be pumped back and forth between the Mixing chamber 452 and the Mixing chamber 450. The lysate may be pumped back and forth by alternating pressurization through the valve 408h (with venting through the valve 408n) and the valve 408g (with venting through the valve 408o). In order to minimize air generation, the chamber liquid sensors (e.g., sensors 428d and 428e) may monitor fluid flow to ensure neither the chamber 452 nor the chamber 450 is fully drained. Flow between the chamber 452 and the chamber 450 may allow mixing of the MB lyo particle 454 into the lysate. A heating rate of the fluid may be increased by mixing the fluid with itself. Mixing the fluid with itself may improve a heating rate because the heat source may be applied on one side of the liquid volume, reducing an amount of time to conduct the heat compared to when the liquid is in a static state. The region may include controlled heating during hybridization to promote capture of the sample target RNA to the paramagnetic particles.-32- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0106] After hybridization and mixing of the lysate, the lysate may be moved back toward the lysis chamber 432. For example, the lysate may move through the PCA chamber 456. A magnet 458 may interface with the PCA chamber 456 to pull the paramagnetic particles to a PCA foil (e.g., a heating element 122), thus separating the particles from the lysate. This may be referred to as a solid phase extraction. Flow of the lysate back to the lysis chamber 432 may occur by pressurizing through opened valves 408g and 408h and opening the valves 408p and 408k to allow flow to the lysis chamber 432. This process may ensure balanced draining of both chamber 450 and chamber 452. In various examples, the PCA inlet sensor 428c may detect when all of the lysate has been purged from the PCA chamber 456.
[0107] In various examples, a plurality of wash buffers may be enabled for use in the cartridge 100. For example, two wash buffers may be used. In various examples, the first wash buffer may be a more aggressive chemistry that may be more inhibitory to a final PCA reaction relative to the second wash buffer. For example, the first wash buffer may include water, 0.017M of MgCh, 0.1 IM of Tris-HCL for a pH of 8.0, and 0.056% of Tween® 20. In various examples, NaCl or KC1 may be utilized rather than MgCh.The first wash buffer may be enabled by opening the frangible seals 410c and / or 410d of the wash buffer blister device 424a. The first wash buffer may then be moved from the blister device 424a through the PCA chamber 456 by pressurizing through the valves 408c and 408i. Valves 408q, 408n, and 408o may be open to allow fluid flow. The volume of the first wash buffer may be controlled using the sensors 428d and 428e positioned within the instrument such that the sensor aligns with and senses fluid in the hybridization chambers. In various examples, the blister device 424a need not be fully emptied in order to minimize air passing downstream through a common channel to the PCA chamber 456. After passing a controlled volume of the first wash buffer through the PCA chamber 456, flow may be reversed by pressurizing valve 408g and 408h and opening valves 408q, 408i, and 408j to allow fluid flow. The first wash buffer may be returned to the blister device 424a until the end of the fluid flow is detected (e.g., by any sensor 428). Responsive to the detection of the end of the fluid flow, additional air and / or liquid may be purged to the lysis chamber 432.
[0108] In various examples, the second wash buffer may be a less aggressive chemistry that may be less inhibitory to a final PCA reaction relative to the first wash buffer. For example,-33- 4923-4563-8928.1Atty. Dkt. No.: 86357077the second wash buffer may include 0.01 M Tris buffer composition, 0.1 M NaCl, and 0.0015 M KC1, with a pH 8.0 at 25 degrees Celsius and 0.01% Tween® 20 when dissolved in one liter of deionized water. In some cases, the second wash buffer may include the same or a similar composition to the first wash buffer (e.g., water, 0.017M of MgCh, 0.1 IM of Tris-HCL for a pH of 8.0, and 0.056% of Tween® 20). The second wash buffer may be enabled by opening the frangible seals 410e and 410f of the wash buffer blister device 424b. The second wash buffer may then be moved from the blister device 424b through the PCA chamber 456 by pressurizing through the valve 408c. Valves 408r, 408n, and 408o may be open to allow fluid flow. The volume of the second wash buffer may be controlled using the sensors 428d and 428e positioned within the instrument such that the sensors align with and sense fluid in the hybridization chambers. In various examples, the blister device 424b need not be fully emptied in order to minimize air passing downstream through a common channel to the PCA chamber 456. After passing a controlled volume of the second wash buffer through the PCA chamber 456, flow may be reversed by pressurizing through the opened valves 408g and 408h and opening valves 408r and 408j to allow fluid flow. The second wash buffer may be returned to the blister device 424b until the end of the fluid flow is detected (e.g., by any sensor 428). Responsive to the detection of the end of the fluid flow, additional air and / or liquid may be purged to the lysis chamber 432.
[0109] In various examples, the PCA buffer 440 may be metered (e.g., at the PCA buffer metered section 442). The PCA buffer blister valves 410g and 410h may be opened. Flow may then move out of the PCA buffer 440. Flow may be moved out by sucking flow at the valve 408f and opening the valves 408e and 4081 to allow flow. A bubble trap 420d may be used to catch air from the PCA buffer 440 that moves downstream. The PCA buffer 440 may continue to fill the PCA buffer metered section 442 until the PCA buffer 440 is sensed by the PCA buffer metering sensor 428f.
[0110] After the PCA buffer flows past a location aligned with the sensor 428f, the valve 408e is closed and the valve 408m is opened to allow pressurized air to separate remaining PCA buffer from a controlled metered PCA buffer volume. The metered volume may be sucked into the master mix (MM) mixing chamber 444, and the master mix lyo bead may be-34- 4923-4563-8928.1Atty. Dkt. No.: 86357077reconstituted. Flow may be stopped responsive to a trailing meniscus of the PCA buffer is sensed by the PCA buffer metering sensor (e.g., the sensor 428f).[OHl] The master mix (MM) lyo material may be mixed well into the PCA buffer. The MM lyo material may be mixed into the PCA buffer by recirculating flow between the MM metering section and the MM mixing chamber 444. Flow may be recirculated by alternating positive and negative pump pressure with valve 408f and valve 408m open. Once mixing is complete, the master mix is pulled into the metering channels and out of the mixing chamber 444.
[0112] Responsive to the master mix being fully mixed, the master mix may be loaded into the PCA chamber 456. The master mix may enter the PCA chamber 456 by applying a vacuum to valve 408h, with valves 408s and 408m open to allow fluid flow. The master mix may enter the PCA well until a trailing liquid meniscus of the master mix arrives at a location corresponding to the PCA inlet sensor 428c.
[0113] Responsive to the master mix arriving at the PCA chamber 456, PCA may be performed. The PCA chamber 456 may be pressurized via the valve 408h to reduce an impact of air bubble growth during PCA temperature cycling. After pressurization, the chamber may be isolated from the pump by closing all valves of the cartridge 100. An isothermal temperature in the PCA chamber 456 may be controlled via a plurality of heaters on each side of the PCA chamber 456. In various examples, electrical pulsing of the PCA foil (e.g., the heating element 122) may create temperature pulses for the PCA reaction.
[0114] Referring now to FIG. 5, a method 600 for detecting the presence, absence, amount, etc. of a nucleic acid of interest, is shown according to some examples. Generally, a user may input an amount of sample (e.g., such as swab specimen eluted in a transport media) into the cartridge 100. The cartridge 100 may meter a proper amount of the sample and system composition 106, and internal positive control (IPC) may be added. The target organisms in the sample and IPC are lysed. Nucleic acids from target organisms and IPC may hybridize (e.g., bind) to paramagnetic particles. Paramagnetic particles with bound capture oligonucleotides may be captured onto a pulse heater in the detection chamber 120 with a magnetic field. The detection chamber 120 and captured magnetic particles 116 are washed with stored wash buffer 110. PCA buffer 440 may be metered and used to reconstitute Master -35- 4923-4563-8928.1Atty. Dkt. No.: 86357077Mix reagent used for PCA. Reconstituted Master Mix reagent may be loaded into the detection chamber 120 with trapped magnetic particles. PCA (e.g., RT-PCA) is performed with realtime multi-channel detection. Results of PCA and detection of target nucleic acids are reported to the user.
[0115] At block 602, a specimen sample may be collected. The specimen sample may be a biological sample collected from, for example, a human that contains a molecule of interest. For example, the biological sample may include nucleic acids of interest. A molecule of interest may be a molecule to be amplified and detected. The molecule of interest may be used for various purposes, such as diagnosing the person that the specimen sample belongs to. In various examples, the specimen sample may be collected by a nasal swab or other retrieval device. Further, the specimen sample may be collected from the person and eluted in a commercial transport medium, such as Copan UTM ®, to be input into the cartridge 100. At block 604, the sample may be input into the cartridge 100. For example, the sample may be input into the sample input chamber (e.g., similar or equivalent to the first fluid chamber 143 and / or the sample input chamber 412).
[0116] At block 606, the volume of the specimen inserted into the cartridge may be metered so that the sample volume used in the detection process is at or around the predefined value. For example, 320 microliters of the specimen may be collected, and the volume may be metered to 300 microliters to be inserted into the cartridge. Metering a sample may include, for example, utilizing the sample as stored in the cartridge 100 or as delivered by a user, a defined volume between a liquid sensor and a cut-off junction, and / or a defined volume between an overflow valve and a cut-off junction. For example, as discussed above with respect to FIG.1, metering a sample may include determining that the sample is detected simultaneously by two sensors (e.g., the first fluid detection sensor 135 and the second fluid detection sensor 137) in a fluid channel, where the volume of the fluid channel between fluid detection locations (e.g., the first detection location 149 and the second detection location 151) is equal to or exceeds the target sample volume.
[0117] For example, referring to the diagnostic system 400 of FIG. 4, the volume of a sample inserted into the cartridge (e.g., into the sample input chamber 412) may be metered so that the-36- 4923-4563-8928.1Atty. Dkt. No.: 86357077sample volume used in the detection process is at or around a predefined value or exceeds a predefined threshold volume. Valve 408a may be opened to fluidly couple the sample input chamber 412 to the pump interface 404, and valve 408k may be opened to fluidly couple the lysis chamber 432 to the vent membrane 448. The pump 402 may then pressurize the channel upstream of the sample input chamber 412, forcing the sample downstream through the bubble trap 420a and into the metering channel 421. The instrument 150 includes an upstream sensor (sensor 428a) arranged to detect fluid in the metering channel 421 at a first, upstream position and a downstream sensor (sensor 428b) arranged to detect fluid in the metering channel 421 at a second, downstream position. The sensors 428a, 428b may be positioned such that the volume of the channel between the first, upstream position and the second, downstream position is equal to the predefined sample volume. This may be a volume of sample that ensures a high degree of reliability of the diagnostic test performed by the diagnostic system 400. Thus, if the sample fills the entirety of the metering channel 421 between the first, upstream position and the second, downstream position, the sample is of sufficient volume to conduct the test with the high degree of reliability. A process for ensuring that the sample volume is sufficient for downstream processes is discussed in further detail below with respect to FIG. 16.
[0118] At block 616, the system composition (e.g., system composition 106) may be stored. For example, the system composition 106 may be stored in a blister device attached to the cartridge and / or a sealed chamber integrated into the cartridge body. The system composition 106 may be used for lysis and / or hybridization. For example, the system composition 106 may be stored in a blister device and transported to the lysis chamber 145 and / or the extraction chamber 114b for use in lysing the biological sample and / or hybridizing the nucleic acids of interest of the lysed biological sample.
[0119] In various examples, the system composition 106 may comprise water, salt, a buffering compound, and / or surfactants. The system composition 106 may include relatively high concentrations of salts. Types of salts found in the system composition 106 may include, for example, KC1, MgCh and / or NaCl. In various examples, the surfactant may be Tween® 20. Further, the cartridge 100 may contain a certain volume of the system composition 106. For example, the cartridge 100 may include between 300 and 800 microliters of the system-37- 4923-4563-8928.1Atty. Dkt. No.: 86357077composition 106. For example, the cartridge 100 may include 500 microliters of the system composition 106. At block 618, the volume of the system composition 106 may be metered so that the system composition volume used in the lysing and / or hybridization processes is at or around the predefined value. For example, 465 microliters of the specimen may be collected, and the volume may be metered to 450 microliters to be transported to and / or used in the lysis chamber 145 and / or the hybridization chamber 114b.
[0120] At block 620, the wash buffer (e.g., wash buffer 110) may be stored. For example, the wash buffer 110 may be stored in a blister device attached to the cartridge and / or a sealed chamber integrated into the cartridge body. The wash buffer 110 may be used for washing magnetic particles (e.g., magnetic particles 116) and / or the detection chamber 120. For example, the wash buffer 110 may be stored in a blister device and transported to detection chambers 120 (e.g., a PCA chamber) for use in washing the detection chamber to prepare for amplification and detection of the nucleic acids of interest of the biological sample.
[0121] In various examples, the wash buffer 110 may comprise water, salt, a buffering compound, and / or surfactants. The wash buffer 110 may include moderately high concentrations of salts (e.g., relative to the salt concentrations in the system composition 106). Types of salts found in the wash buffer 110 may include, for example MgCh and / or NaCl. In various examples, the surfactant may be Tween® 20. The wash buffer 110 may also include KC1. Further, the cartridge 100 may contain a certain volume of the wash buffer 110. For example, the cartridge 100 may include between 100 and 400 microliters of the wash buffer 110. For example, the cartridge 100 may include 250 microliters of the wash buffer 110. In various examples, the cartridge 100 may include a plurality of wash buffers 110, each having a different composition and / or different uses. For example, a first wash buffer may include a stronger washing agent, and a second wash buffer may be milder. For example, the first wash buffer 110 may include 0.05 M tris buffer, 0.15 M NaCl, 0.0025 M KC1, and 0.05% Tween® 20, while the second wash buffer 110 may include 0.025 M tris buffer, 0.05 M NaCl, 0.0015 M KC1, and 0.01% Tween® 20. The first wash buffer may be used to wash the detection chamber 120, and the second wash buffer may be used to rinse the detection chamber 120.-38- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0122] At block 622, the PCA buffer (e.g., PCA buffer 440) may be stored. For example, the PCA buffer 440 may be stored in a blister device attached to the cartridge and / or a sealed chamber integrated into the cartridge body. The PCA buffer 440 may be used to reconstitute a master mix reagent used for reverse transcription and PCA amplification (e.g., the amplification process). For example, the PCA buffer 440 may be stored in a blister device and transported to detection chambers 120 (e.g., a PCA chamber) for use preparing for amplification of the nucleic acids of interest.
[0123] In various examples, the PCA buffer 440 may comprise water and / or salt. The PCA buffer 440 may include small concentrations of salts (e.g., relative to the salt concentrations in the system composition 106 and / or the wash buffer 110). Types of salts found in the wash buffer 110 may include, for example MgCh. In various examples, the PCA buffer 440 may include a surfactant (e.g., Tween® 20) and / or a buffering compound. Further, the cartridge 100 may contain a certain volume of the PCA buffer 440. For example, the cartridge 100 may include between 100 and 400 microliters of the PCA buffer 440. For example, the cartridge 100 may include 200 microliters of the PCA buffer 440.
[0124] At block 624, the volume of the PCA buffer 440 may be metered so that the PCA buffer volume used in the reconstitution process is at or around the predefined value. For example, 235 microliters of the specimen may be collected, and the volume may be metered to 60 microliters to be transported to and / or used in the detection chamber 120 Metering the PCA buffer 440 may control a concentration of the subsequently reconstituted master mix reagent, which may ensure proper amplification of the nucleic acids of interest. In various examples, the PCA buffer 440 may be metered by pumping the PCA buffer 440 through a defined volume between a liquid sensor and a fluidic T-junction bisecting the PCA buffer. Air may then be pumped into the T-junction such that a defined volume of the PCA buffer 440 is further transported.
[0125] At block 626, a PCA master mix reagent may be reconstituted. A master mix may be used for reverse transcription, PCA amplification, and / or real-time fluorescence detection. The master mix may be lyophilized (e.g., freeze dried). The PCA master mix reagent may be stored,-39- 4923-4563-8928.1Atty. Dkt. No.: 86357077for example, in a lyophilized pellet or cake, an air-dried pellet or cake, and / or sealed with a plastic plug or film.
[0126] In various examples, the PCA master mix reagent may include a plurality of active ingredients, such as: reverse transcriptase, polymerase, and dNTPs. For each reaction target, the master mix reagent may include a set of primers (e.g., one half of a primer pair used in PCR) and a fluorescent probe. In various examples, lyophilization excipients may include sugars, such as, for example, trehalose.
[0127] At block 628, the biological sample may be lysed, stored with internal positive control (IPC), and mixed with system composition. For example, the metered biological sample may be transported to the lysis chamber 145. The system composition 106 and the IPC may be added to the lysis chamber 145 prior to, concurrent with, and / or subsequent to addition of the biological sample to the lysis chamber 145. The IPC may be a lyophilized organism or synthetic organism. In various examples, the IPC may be a protein and / or organism present in a human sample. At block 628, the sample, the system composition, and the IPC may be mixed using sonication. For example, the lysis system 152 may be coupled with the lysis chamber 145. The sonicator 133 may perform sonication to mix the sample, buffer, and IPC. In some examples, the biological sample may only be moved into the lysis chamber 145after confirming at block 606 that the sample has sufficient volume for analysis.
[0128] In various examples, the lysis chamber 145 may be heated by an external heater and / or the sonicator 133. Sonication may induce cavitation upon organisms (e.g., the IPC). In various examples, small beads or particles (e.g., ceramic beads, glass beads) may be included in the lysis chamber 145. The beads or particles may be agitated to mechanically lyse the solution. In various examples, lysis may result from heat, cavitation, and / or the lysing beads.
[0129] At block 630, potential targeted nucleic acids in the solution lysed at block 628 may be hybridized to stored functionalized paramagnetic particles (e.g., magnetic particles 116). The solution lysed in the lysis chamber 145 may be referred to as a “lysate.” The lysate may be transported to the hybridization chamber 114b. In the hybridization chamber 114b, the lysate may reconstitute lyophilized paramagnetic particles. The lyophilized paramagnetic particles may be functionalized with capture oligonucleotides that may be designed to capture RNA -40- 4923-4563-8928.1Atty. Dkt. No.: 86357077and / or DNA strands from target organisms. The oligonucleotides may be utilized as a half of a primer pair during amplification (e.g., during the PCA amplification reaction).
[0130] During hybridization, the magnetic particles 116 may be mixed and agitated with the lysate. Mixing and agitation may optimize a capture efficiency of the target nucleic acids. In various examples, hybridization may occur between 55 and 65 degrees Celsius. For example, hybridization may occur at 62 degrees Celsius. In various examples, hybridization may occur with a high salt content (e.g., MgCh or NaCl). Mixing may occur, for example, by reciprocating flow between two chambers (e.g., a first hybridization chamber 114b and a second hybridization chamber 114b such that vortices form at an entrance of each chamber to mix the lysate with the magnetic particles 116.
[0131] At block 632, the magnetic particles 116 are trapped onto a heating element (e.g., the heating element 122) in the detection chamber 120 (e.g., a PCA chamber). The heating element 122 may be or include, in various examples, a continuous, structured, or shaped metal foil, metal wires, a conductor and / or resistor layer deposited and / or plated, and / or backed by a heat spreader. In various examples, in order for the PCA process to occur, the paramagnetic particles with the captured nucleic acids may be concentrated at a thermocycling zone of the heating element. Thus, after hybridization, the lysate hybridized with the magnetic particles may be transported to the detection chamber 120, where the particles are “trapped” or otherwise attached to the heating element 122.
[0132] The lysate may be delivered to the detection chamber 120. An external permanent magnet (e.g., magnetic field generator 156) may create a magnetic field. The generated magnetic field may attract the paramagnetic particles onto a surface of the heating element 122. The lysate may then be disposed. For example, the lysate may be stored in a location of the cartridge (e.g., the blister device used to store the system composition 106). In various examples, the magnetic particles may be distributed uniformly across the heating element 122. Further, in various examples, a flow of the lysate may be continuous, in discrete steps, or any combination thereof.
[0133] At block 634, the detection chamber 120 is washed using the wash buffer (e.g., the wash buffer 110). Washing the detection chamber 120 may remove undesirable components in the -41- 4923-4563-8928.1Atty. Dkt. No.: 86357077detection chamber 120 and / or on the magnetic particles 116 that may interfere with amplification of the nucleic acids of interest. The wash buffer 110 may be pumped through the detection chamber 120 to wash the chamber. Upon washing, the wash buffer 110 may return to the blister device storing the wash buffer. In various examples, a volume, time, flow rate, and / or flow directionality may be adjusted based on needs of the amplification and / or assay.
[0134] At block 626, as stated above, the PCA master mix reagent is reconstituted. In various examples, a metered amount of the master mix may be used to reconstitute the master mix reagent. The master mix reagent may be lyophilized. The PCA buffer 440 may be mixed with the master mix by reciprocally pumping between a storage chamber storing the original master mix reagent and a channel leading to the chamber.
[0135] At block 636, the detection chamber 120 is loaded with the reconstituted master mix reagent. In order for amplification to be performed, the master mix reagent may be located in the detection chamber 120 where temperature incubation and / or thermocycling occurs. In various examples, air bubbles may interfere with optical detection of the nucleic acid of interest. Thus, the system may remove any air bubbles in the detection chamber 120 after the master mix reagent is loaded. Air bubbles may be managed, for example, by air bubble traps with stagnant chamber geometries, hydrophobic vent membranes over a channel or chamber, columns, posts, filters, elongated vertical chambers for buoyant bubble collection, etc. In various examples, air may be minimized to reduce movement when the solution is heated. Specifically, air on at least one send of the reaction solution may be minimized. For example, a valve may be positioned on entrances and / or exits to the detection chamber 120 to remove air from the detection chamber 120.
[0136] At block 638, amplification is performed. In various examples, amplification may be or include a PCA reaction. Upon amplification, a real-time multi-channel detection may be performed to detect the nucleic acids of interest. For example, the optical unit 162 may detect an absence, presence, and / or amount of the nucleic acid of interest. In various examples, detection may be performed using optical fluorescence and / or electrochemical detection with functionalized surfaces.-42- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0137] At block 640, the results of the amplification may be analyzed and presented. For example, the results may be analyzed to determine a presence, absence amount, etc. of the nucleic acid of interest. The results may be displayed, for example, via a user interface.
[0138] As discussed above with respect to FIG. 1 and block 606 of FIG. 5, upstream and downstream sensors configured to detect fluid in a metering channel may be used to ensure that the sample volume meets or exceeds a threshold volume. FIGS. 6-15 illustrate various scenarios in which a sample fluid is moved or attempted to be moved through a metering channel (e.g., the fluidic channel 147, the SI metered section 430) and the accompanying sensor data from the upstream and downstream sensors. The metering channel may be used to determine and control an amount of fluid (e.g., sample fluid, buffer fluid, etc.) that has traveled therethrough based on data from fluid detection sensors positioned along the metering channel (e.g., the fluid detection sensors 135, 137, the sensors 428a, 428b). Referring now to FIG. 6, a cartridge 100 is shown according to an example. The cartridge 100 may be similar or the same as the cartridge in the diagnostic system 400 of FIG. 4. In FIG. 6, the channel upstream of the sample input chamber 412 has been pressurized, forcing the sample through the bubble trap 420a and into the metering channel 421. For example, as discussed above with respect to FIG.4, the valve 408a (as shown in FIG. 4) may be opened to fluidly couple the sample input chamber 412 to the pump interface 404, and valve 408k may be opened to fluidly couple the lysis chamber 432 to the vent membrane 448. The pump 402 may then pressurize the pressurization channel 419 of the sample input chamber 412, forcing the sample downstream through the bubble trap 420a and into the metering channel 421. The sample fluid travels through the metering channel 421 toward the lysis chamber 432. As shown in FIG. 6, the sample fills the entire metering channel 421 between the first, upstream detection location 701 (e.g., similar or equivalent to the first detection location 149 discussed above with respect to FIGS. 1 and 2 and corresponding to the location of the sensor 428a when the cartridge 100 is inserted into the instrument 150) and the second, downstream detection location 703 (similar or equivalent to the first detection location 149 discussed above with respect to FIGS. 1 and 2 and corresponding to the location of the sensor 428b when the cartridge 100 is inserted into the instrument 150), forming a single slug 705 of fluid. A fluid “slug” may refer to a contiguous segment of fluid in the metering channel 421, uninterrupted by air gaps or bubbles.-43- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0139] FIG. 7 shows a graph 800 of sensor data recorded from the upstream sensor 428a of FIG. 6 (indicated by line 801) and the downstream sensor 428b of FIG. 6 (indicated by line 803). The sensor data is shown as sensor values (y-axis) recorded over time, in seconds (x-axis). As shown in graph 800, a sensor value at or above about 9000 indicates that no fluid is detected by the respective sensor, and a sensor value below about 6000 indicates that fluid is detected by the respective sensor. Sensor values between about 6000 and about 9000 may indicate that some fluid is detected but that the fluid does not fill the entire channel at the respective detection location 149, 151. Thus, the “sensor value” detected by the fluid detection sensors as shown in FIG. 7 may be considered the inverse of a detected “wetness value.” For example, a sensor value below 6000 may indicate a wetness value above a threshold (e.g., where the metering channel is completely or substantially completely filled with fluid at the fluid detection location associated with the sensor). A sensor value above 9000 may indicate that no fluid or substantially no fluid is detected and may correspond to a low or zero wetness value. A sensor value between 6000 and 9000 may indicate a wetness value above zero but below the threshold, indicating that the channel may be partially filled with fluid at the fluid detection location associated with the sensor.
[0140] As indicated by line 801, the upstream sensor 428a of FIG. 6 begins detecting the sample at about the 11 -second mark (when the sensor value falls below 9000) and continues detecting fluid to the 20-second mark. The sensor value from the upstream sensor 428a being below 6000 (from about the 11 -second mark to the 20-second mark) may indicate that the metering channel 421 is completely filled with sample fluid at the upstream detection location 701 from about the 12-second mark to the 20-second mark. As indicated by line 803, the downstream sensor 428b of FIG. 6 sensor begins detecting the sample at about the 15-second mark and continues detecting fluid to the 20-second mark. The sensor value from the downstream sensor 428b being below 6000 (from about the 16-second mark to the 20-second mark) may indicate that the metering channel 421 is completely filled with sample fluid at the downstream detection location 703 from about the 16-second mark to the 20-second mark. Thus, the sensor data may be used to determine when fluid is detected at the upstream detection location 701 and the downstream detection location 703 of the metering channel 421 in the cartridge 100 of FIG. 6. Based on when fluid is detected and for how long, a total volume of fluid that had travelled through the metering channel 421 may be determined. In some -44- 4923-4563-8928.1Atty. Dkt. No.: 86357077examples, a controller (e.g., the controller 141 of FIGS. 1 and 2) may determine, based on the sample being detected by the upstream sensor 428a and the downstream sensor 428b of FIG. 6 simultaneously, that the sample fills the entirety of the metering channel 421 between the upstream detection location 701 and the downstream detection location 703 and therefore is of sufficient volume for analysis (e.g., that the sample volume meets a threshold volume). Upon determining that the sample is detected simultaneously by both sensors 428a, 428b and is of sufficient volume, the controller 141 may move the sample into the lysis chamber 432 and proceed with downstream processes in the sample analysis process. In other examples, determining that the sample volume is sufficient may include determining that the upstream sensor 428a detects fluid the entire time period between an initial detection of fluid by the upstream sensor 428a and an initial detection of fluid by the downstream sensor 428b, which may confirm that there are no air gaps in the fluid slug 705. FIGS. 8-15 illustrate additional examples of determining the volume of the sample fluid and confirming that the sample fluid volume exceeds a threshold volume. As discussed above, the threshold volume of sample fluid may be an amount of sample fluid that ensures a reliable analysis of the sample in a downstream process. For example, the system 100 A may be configured to detect a particular nucleic acid in the sample fluid, and the threshold volume may be a volume of sample fluid that ensures that the nucleic acid can be reliably detected if present.
[0141] Referring now to FIG. 8, the metering channel 421 is shown with a sample of insufficient volume, for comparison with the sample of FIG. 6. As shown in FIG. 7, the sample has reached the downstream detection location 703 (corresponding to the location of the downstream sensor 428b), but because the volume of the sample is less than the threshold volume, the sample has entirely passed the upstream detection location 701 (corresponding to the location of the downstream sensor 428a). Thus, the sample forms a fluid 903 (a contiguous segment of fluid in the metering channel 421, uninterrupted by air gaps or bubbles) that has reached the downstream detection location 703 but does not extend to the upstream detection location 701. FIG. 9 shows a graph 1000 of sensor data recorded from the upstream sensor 428a (indicated by line 1001) and the downstream sensor 428b (indicated by line 1003). The sensor data is shown as sensor values (y-axis) recorded over time, in seconds (x-axis). As shown in graph 1000, a sensor value above about 9000 indicates that no fluid is detected by the respective sensor, and a sensor value below about 6000 indicates that fluid is detected by the -45- 4923-4563-8928.1Atty. Dkt. No.: 86357077respective sensor. Sensor values between about 6000 and about 9000 may indicate that some fluid is detected but that the fluid does not fill the entire channel at the respective detection location 701, 703. As indicated by line 1001, the upstream sensor 428a (shown in FIG. 4 and arranged to detect fluid at the upstream detection location 701) begins detecting the sample at about the 10-second mark but stops detecting the sample at about the 14-second mark. As indicated by line 1003, the downstream sensor 428b (shown in FIG. 4 and arranged to detect fluid at the downstream detection location 703) sensor begins detecting the sample at about the 15-second mark and continues detecting fluid to the 20-second mark. Because the upstream sensor 428a and the downstream sensor 428b do not simultaneously detect the sample, the controller 141 may determine that the sample volume does not exceed the threshold volume and may be insufficient for reliable analysis. In some examples, the controller 141 may determine that the sample volume does not meet the threshold volume based on the upstream sensor 428a detecting fluid and then not detecting fluid before fluid is detected by the downstream sensor 428b. In some examples, the controller 141 may stop the analysis of the sample based on determining that the sample volume does not meet the threshold volume. The controller 141 may send a message to an operator of the diagnostic system 400 (e.g., to a user interface of the instrument 150, to an external computing system, to a mobile device, etc.) indicating that the sample is of insufficient volume for analysis.
[0142] In some examples, a controller (e.g., the controller 141 of FIGS. 1 and 2) may estimate the volume of the sample based on the amount of time that the upstream sensor 428a detects fluid before fluid is detected at the downstream sensor 428b and flow is stopped. For example, it may be determined based on experimental testing that fluid tends to flow through the metering channel 421 at about 100 microliters per second. If the controller 141 determines that the upstream sensor 428a detects fluid for three seconds before no longer detecting fluid, the controller 141 may determine or estimate that the sample volume is about 300 microliters and thus below the threshold volume of 320 microliters. In some examples, analysis of the sample may be aborted and the cartridge 100 may be ejected from the instrument 150 (e.g., of FIGS. 1 and 2) upon the determination that the sample volume is below the threshold volume. However, as discussed above, in some examples, it may be preferable to proceed with analysis of a sample even if the sample volume does not meet the threshold volume. In some cases, if the sample volume is only slightly lower than the threshold volume, the analysis of the sample -46- 4923-4563-8928.1Atty. Dkt. No.: 86357077may be only slightly less reliable than if the threshold volume is met. For example, if the sample fluid volume exceeds the threshold volume, a target nucleic acid in the fluid sample may be detected with 99 percent accuracy, and if the sample fluid volume is less than 10 percent lower than the threshold volume, the target nucleic acid in the fluid sample may be detected with 97 percent accuracy. In some examples, a positive diagnostic test result (e.g., a detection of the target nucleic acid) may require a smaller sample volume than a negative test result. For example, a small sample (e.g., under the threshold volume) with a high viral load may return a positive test (e.g., a detection of the target nucleic acid), but a small sample with a low viral load may be prone to false negatives (e.g., no detection of the target nucleic acid despite the target nucleic acid being present in the sample). Thus, if a sample with a volume below the threshold volume is tested, the test may indicate that a positive test result is associated with high degree of confidence, while a negative test result may be associated with a lower degree of confidence.
[0143] In some examples, the controller 141 may send a message to a user interface prompting a user to indicate whether analysis of the sample should continue despite the sample volume not meeting the threshold volume, whereas, in some examples, analysis may continue automatically, without user intervention, if the sample volume meets the threshold volume. For example, if the controller 141 estimates that the sample volume is 300 microliters and the threshold volume is 320 microliters, the controller 141 may send a message to the user interface indicating estimated volume and asking the operator of the diagnostic system 400 whether to continue with the test. The operator may select an option via the user interface instructing the controller 141 to continue with analysis or may cancel the analysis. If the user instructs the controller 141 to proceed with analysis, the controller 141 may modify a record to indicate that the sample volume did not meet the threshold volume and that the test results may have a lower degree of confidence or reliability. Because the sample metering process is performed at the beginning (e.g., in the first two minutes) of the analysis of the sample, a substantial amount of time can be saved (e.g., over eighteen minutes of a twenty minute analysis process) by canceling or aborting the analysis at this stage when the sample volume is determined to be insufficient.-47- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0144] In some examples, the controller 141 may perform additional analysis on the data from the sensors 428a, 428b of FIG. 4 to determine whether the sample volume meets a threshold volume. For example, referring now to FIG. 10, the metering channel 421 is shown with a sample having a volume of air (e.g., a bubble) that has passed the bubble trap 420a and entered the metering channel 421. As shown in FIG. 10, the sample has formed a first fluid slug 1101 and a second fluid slug 1103 with a gap 1105 therebetween. FIG. 11 shows a graph 1200 of sensor data from the upstream sensor 428a (indicated by line 1201) and the downstream sensor 428b (indicated by line 1203). The sensor data is shown as sensor values (y-axis) recorded over time, in seconds (x-axis). As shown in graph 1200, a sensor value above about 9000 indicates that no fluid is detected by the respective sensor, and a sensor value below about 6000 indicates that fluid is detected by the respective sensor. Sensor values between about 6000 and about 9000 may indicate that some fluid is detected but that the fluid does not fill the entire channel at the respective detection location 701, 703. As indicated by line 1201, the upstream sensor 428a begins detecting the sample at about the 10-second mark, stops detecting the sample at about the 13-second mark, begins detecting the sample again at the 15-second mark, and continues detecting the sample to the 20-second mark, indicating the detection of the first fluid slug 1101, followed by the gap 1105, followed by the second fluid slug 1103. As indicated by line 803, the downstream sensor 428b sensor begins detecting the sample at about the 16-second mark and continues detecting fluid to the 20-second mark, indicating the detection of the first fluid slug 1101 (with the flow of fluid being stopped upon detection of the first fluid slug 1101). Despite the upstream sensor 428a and the downstream sensor 428b simultaneously detecting the sample (e.g., at the 16-second mark), the controller 141 may determine that the sample volume (or at least the volume of a portion of the sample between the upstream detection location 701 and the downstream detection location 703) does not meet the threshold volume because of the upstream sensor 428a did not detect the sample for a period of time between initially detecting the sample and detecting the sample at the same time that the downstream sensor 428b detects the sample (e.g., between the 13-second mark and the 15-second mark). In some examples, the controller 141 may stop the analysis of the sample based on determining that the sample volume (or at least the volume of a portion of the sample between the upstream detection location 701 and the downstream detection location 703) does not meet the threshold volume. The controller 141 may send a message to an operator of the-48- 4923-4563-8928.1Atty. Dkt. No.: 86357077diagnostic system 400 (e.g., via the user interface 153) indicating that the sample is of insufficient volume for analysis.
[0145] As discussed above, with respect to FIG. 8, in some examples, the controller 141 may estimate the volume of the sample based on the amount of time that the upstream sensor 428a detects fluid before the before fluid is detected at the downstream sensor 428b and flow is stopped. For example, if the flow rate of the sample is presumed to be 100 microliters per second, and the sample is detected for one second, not detected for three seconds, and then detected again for another second, the controller 141 may estimate that the volume of the sample (or at least the volume of a portion of the sample between the upstream position 701 and the downstream position 703) is 200 microliters. As discussed above, in some examples, the controller 141 may send a message to a user interface prompting a user to indicate whether analysis of the sample should continue despite the sample volume not meeting the threshold volume.
[0146] In some examples, when a bubble or gap (e.g., a gap 1105 as shown in FIG. 10) is detected in the metering channel 421 based on the upstream sensor 428a briefly not detecting the sample before detecting the sample a second time (e.g., an increase in the sensor value received from the upstream sensor 428a followed by a decrease in the in the sensor value received from the upstream sensor 428a as illustrated by line 1201 FIG. 11), there may be additional sample volume (e.g., the sample portion 1107 as shown in FIG. 10) upstream of the upstream detection location 701 that has not yet reached the upstream sensor 428a. Thus, the sample may have a volume that meets the threshold volume even if the volume of the portion of the sample between the upstream detection location 701 and the downstream detection location 703 is less than the threshold volume. In some examples, when a bubble is detected in the metering channel 421 (e.g., based on a temporary increase in the sensor value received from the upstream sensor 428a as discussed above), the controller 141 of FIGS 1 and 2 may cause the pump 402 of FIG. 4 to pressurize the channel upstream of the sample input chamber 412 a second time (i.e., after the pump was pressurized a first time to move the first fluid slug 1101 and the gap 1105 into the metering channel 421) to move additional sample volume into the metering channel 421. This may cause a portion of the sample adjacent the downstream detection location 703 (e.g., the first fluid slug 1101) and the bubble to move into the lysis-49- 4923-4563-8928.1Atty. Dkt. No.: 86357077chamber 432. The controller 141 may estimate or determine how long to operate the pump based on the estimated volume of the portion of the sample between the upstream detection location 701 and the downstream detection location 703. Continuing the example above in which the controller 141 determined or estimated that the volume of the portion of the sample between the upstream detection location 701 and the downstream detection location 703 is 200 microliters, if the threshold volume is 320 microliters, and the estimated flow rate of the sample through the metering channel 421 is 100 microliters per second, the controller 141 may operate the pump 402 for approximately 1.2 seconds to move an additional 120 microliters of sample fluid into the metering channel 421.
[0147] A similar method may be used in the situation of FIGS. 9 and 10. If, when the sample is detected by the downstream sensor, the sample is no longer detected by the upstream sensor 428a, the controller 141 may continue to cause the pump 402 to attempt to move fluid into the metering channel 421 (or may operate the pump a second time after receiving instructions from a user, for example, via user interface 153). The controller 141 may operate the pump 402 for an amount of time until the controller 141 estimates that the volume of the sample fluid that has been detected by the upstream sensor 428a exceeds a target or threshold volume. For example, if, as shown in FIG. 9, the upstream sensor 428a detects fluid for about 2.5 seconds before the fluid is detected by the downstream sensor 428b, the controller 141 may estimate that the volume of sample fluid in the metering channel 421 is about 150 microliters. Assuming a target or threshold volume of 300 microliters, the controller 141 may operate the pump for additional time to attempt to move any additional sample fluid into the metering channel 421 until the upstream sensor 428a detects fluid for 2.5 more seconds, indicating 150 microliters for a total sample volume of 300 microliters. If there is not 150 microliters left to move into the metering channel 421, the controller 141 may stop operating the pump 402 after a predetermined amount of time and may indicate, via the user interface 153 the total estimate volume of sample that has been moved into the metering channel 421. Based on the total volume, a user may determine whether to continue with analysis of the sample or to eject the cartridge 100 and may provide instructions to the controller 141 via the user interface 153.
[0148] Referring now to FIG. 12, the metering channel 421 is shown with a sample that has passed the upstream position 701 but has not reached the downstream position 703 after a-50- 4923-4563-8928.1Atty. Dkt. No.: 86357077predetermined time limit. This may indicate a problem with the cartridge 100 (e.g., a leak), the pump 402, or another component of the diagnostic system 400. FIG. 13 shows a graph 1400 of sensor data from the upstream sensor 428a (indicated by line 1401) and the downstream sensor 428b (indicated by line 1403). As shown in graph 1400, a sensor value above about 9000 indicates that no fluid is detected by the respective sensor, and a sensor value below about 6000 indicates that fluid is detected by the respective sensor. Sensor values between about 6000 and about 9000 may indicate that some fluid is detected but that the fluid does not fill the entire channel at the respective detection location 149, 151. As indicated by line 1401, the upstream sensor 428a begins detecting the sample at about the 10-second mark and continues detecting the sample through the 20-second mark. However, the downstream sensor 428b never detects the sample. The controller 141 may be configured to operate the pump 402 until (a) the sample is detected by the downstream sensor 428b or (b) a predetermined time limit is reached. If, after the predetermined time limit has been reached and the sample is not detected by the downstream sensor 428b, the controller may cause the pump to stop pressurizing the channel upstream of the sample input chamber 412. In some examples, the controller 141 may stop the analysis of the sample based on determining that the sample did not reach the downstream sensor 428b. In some examples, the controller 141 may send a message to an operator of the diagnostic system 400 (e.g., via a user interface) indicating that the sample has not reached the downstream sensor 428b. The operator may be prompted to instruct the controller 141 to activate the pump 402 a second time to attempt to move the sample through the metering channel 421 to the downstream sensor 428b or to cancel the sample analysis.
[0149] Referring now to FIG. 14, the metering channel 421 is shown in which no sample has reached the upstream position 701. This may indicate that no sample was loaded into the sample input chamber 412, that there is a leak in the cartridge 100 (e.g., in the channel upstream of the sample input chamber 412), that there is a problem with the pump 402 or the connection of the pump 402 to the cartridge 100, or some other problem with the diagnostic system 400 such that the sample does not leave the sample input chamber 412 or otherwise fails to reach the upstream position 701. Other sensors of the instrument 150 may be checked to determine whether there is a leak in the cartridge or a fault in the instrument 150. The instrument 150 may eject the cartridge 100 and indicate that no sample was detected via the user interface 153. FIG. 15 shows a graph 1400 of sensor data from the upstream sensor 428a (indicated by line -51- 4923-4563-8928.1Atty. Dkt. No.: 863570771601) and the downstream sensor 428b (indicated by line 1603). As shown in graph 1600, a sensor value above about 9000 indicates that no fluid is detected by the respective sensor, and a sensor value below about 6000 indicates that fluid is detected by the respective sensor. As indicated by lines 1601 and 1603, neither the upstream sensor 428a nor the pinch valve 408b detects the sample. If, after a predetermined time limit has been reached, the sample is not detected by either sensor 428a, 428b, the controller may cause the pump to stop pressurizing the channel upstream of the sample input chamber 412. In some examples, the controller 141 may stop the analysis of the sample based on determining that the sample did not reach the upstream sensor 428a. In some examples, the controller 141 may send a message to an operator of the diagnostic system 400 (e.g., via a user interface) indicating that the sample has not reached the upstream sensor 428a. The operator may be prompted to instruct the controller 141 to activate the pump 402 a second time to attempt to move the sample into the metering channel 421 or may cancel the sample analysis. The operator may also inspect the cartridge 100 to confirm that the sample was actually deposited into the sample input chamber 412. If the sample input chamber 412 is empty, the operator may insert the sample into the sample input chamber 412 and restart the analysis process.
[0150] Referring now to FIG. 16, a method 1700 for metering fluid into a lysis chamber (e.g., lysis chamber 432) of a cartridge (e.g., the cartridge 100), is shown according to some examples. The method 1700 may be performed, for example, using the diagnostic system 400 including an instrument (e.g., instrument 150) and a cartridge (e.g., cartridge 100). The method 1700 may be performed during or as a part of the method 600. For example, the method 1700 may be part of blocks 606 and 628 of the method 600. As discussed above, the instrument 150 includes a controller 141 that may control operation of the pump 402 and may control the opening and closing of the valves 408 in the cartridge 100 (e.g., pneumatically, magnetically, etc.). The controller 141 may also be communicably coupled to the sensors 428 and configured to receive sensor data from the sensors 428. The sensor data may indicate the detection of fluid in the channels of the cartridge 100 proximate the sensors 428.
[0151] In operation 1702 of the method 1700, at least a portion of sample fluid that has been loaded into a cartridge is moved into a fluidic channel (e.g., a metering channel). For example, a channel upstream of a sample may be pressurized to push the sample into a downstream-52- 4923-4563-8928.1Atty. Dkt. No.: 86357077channel. For example, in the diagnostic system 400, the pump 402 may pressurize the pressurization channel 419, and the valve 408a may be opened to pressurize the sample input chamber 412, causing the sample fluid to flow through the umbrella valve 418 and the bubble trap 420a into the metering channel 421. Valve 408k may also be opened to allow air in the metering channel 421 to be vented through the lysis chamber 432 and the vent channel 445 to the vent membrane 448 so that the sample may flow into the metering channel 421.
[0152] At operation 1704 of the method 1700, first sensor data from a first sensor arranged to detect fluid at a first, upstream detection location in the metering channel is monitored as the sample is moved into the metering channel. The sensor may be positioned in the instrument to detect fluid in the cartridge at the first detection location in the metering channel when the cartridge is in the instrument. For example, in the diagnostic system 400, as the sample in the sample input chamber 412 moves into the metering channel 421, the controller 141 receives sensor data from the sensor 428a. The sensor data may be monitored over time and may indicate whether fluid is detected in the metering channel 421 in a location proximate the sensor 428a. For example, when the sample begins to move into the metering channel 421 the sensor data may indicate (e.g., by providing a value to the controller 141 within a first range of values) that no fluid is detected in the metering channel 421 proximate the sensor 428a. Then, as the sample reaches the location in the metering channel 421 proximate the sensor 428a, the sensor data may indicate (e.g., by providing a value to the controller 141 within a second range of values) that fluid is detected in the metering channel 421 proximate the sensor 428a.
[0153] At operation 1706 of the method 1700, second sensor data from a second sensor arranged to detect fluid at a second, downstream detection location in the metering channel is monitored as the sample is moved through the metering channel. The sensor is positioned in the instrument to detect fluid in the cartridge at the second detection location in the metering channel (downstream of the first detection location) when the cartridge is in the instrument. For example, in the diagnostic system 400, as the sample moves through the metering channel 421, the controller 141 receives sensor data from the sensor 428b. The sensor data may be monitored over time and may indicate whether fluid is detected in the metering channel 421 in a location proximate the sensor 428b. For example, while the sample moves through the metering channel 421 the sensor data may indicate (e.g., by providing a value to the controller-53- 4923-4563-8928.1Atty. Dkt. No.: 86357077141 within a first range of values) that no fluid is detected in the metering channel 421 proximate the sensor 428b. Then, as the sample reaches the location in the metering channel 421 proximate the sensor 428b, the sensor data may indicate (e.g., by providing a value to the controller 141 within a second range of values) that fluid is detected in the metering channel 421 proximate the sensor 428b. When the sample is detected at the second detection location (e.g., by the sensor 428b), the flow of the sample may be stopped. For example, the controller 141 may cause the pump 402 to stop supplying more air into the pressurization channel 419, causing the flow of the sample to stop.
[0154] At operation 1708 of the method 1700, it is determined, based on the first sensor data and the second sensor data, whether the sample is simultaneously detected at the first detection location and the second detection location. The volume of the metering channel between the first sensor and the second sensor may exceed a threshold volume for the sample. Thus, if the metering channel is entirely filled with sample, the volume of the sample is sufficient for lysis. If the sample is simultaneously detected at the first, upstream detection location and the second, downstream detection location (and it can be assumed or determined there are no air pockets or bubbles in the metering channel between the first and second detection locations) it may be determined that the volume of the sample is sufficient for downstream processing and analysis. For example, in the diagnostic system 400 the first and second sensor data received by the controller 141 from the sensor 428a and the sensor 428b may be used to determine whether fluid is detected simultaneously at the first, upstream detection location, and the second, downstream detection location. Determining that fluid is detected at the first, upstream detection location may be based on a wetness value detected by the first, upstream sensor exceeding a first threshold, and determining that fluid is detected at the second, downstream detection location may be based on a wetness value detected by the second, downstream sensor exceeding a second threshold. For example, as discussed above, the fluid detection sensors 135, 137 may provide a numerical “sensor value” indicating the detection of a fluid at the respective detection location 149, 151. The sensor value may decrease when fluid is detected and may reach a minimum when the entire fluidic channel 147 is filled with fluid at the respective detection location 149, 151. Thus, the sensor value may be the inverse of a “wetness value,” indicating how “wet” or filled with fluid the fluidic channel 147 is at the respective detection location 149, 151. For example, a sensor value below a first value (e.g., 6000 as -54- 4923-4563-8928.1Atty. Dkt. No.: 86357077shown in FIG. 7) may indicate a wetness value above a threshold (e.g., where the fluidic channel 147 is completely or substantially completely filled with fluid at the fluid detection location associated with the fluid detection sensor). A sensor value above a second value (e.g., 9000 as shown in FIG. 7) may indicate that no fluid or substantially no fluid is detected and may correspond to a low or zero wetness value. A sensor value between the first value and the second value (e.g., between 6000 and 9000 as shown in FIG. 7) may indicate a wetness value above zero but below the threshold, indicating that the channel may be partially filled with fluid at the fluid detection location 149, 151 associated with the sensor.
[0155] The first threshold and the second threshold may be different or the same, depending, for example, on the relative location of the sensor to the fluidic channel. In some examples, upon confirming that fluid is detected simultaneously at the first, upstream detection location, and the second, downstream detection location, the method 1700 may proceed to operation 1716, and at least the portion of the sample fluid may be moved into the lysis chamber (e.g., lysis chamber 432). In other examples, the method 1700 may proceed to operation 1710 for additional confirmation that the volume of the sample fluid is sufficient.
[0156] At operation 1710, it may be determined, based on the first and second sensor data, whether a wetness value detected by the first (upstream) fluid detection sensor exceeds a first threshold for an entire time period between a first initial detection of the sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor. Said another way, it may be determined whether the sample fluid is detected by the first fluid detection sensor continuously until sample fluid is first detected by the second fluid detection sensor. This may indicate that there are no air bubbles or air pockets in the metering channel between the first, upstream position and the second upstream position. For example, as shown in FIG. 7 and as discussed above, the sensor data from the upstream sensor, indicated by line 801 initially detects the sample at about the 10-second mark and continuously detects fluid until the initial detection of fluid by the downstream sensor at about the 16-second mark, as indicated by line 803. A sensor value below 6000 may indicate a wetness value above a threshold (e.g., where the metering channel is completely or substantially completely filled with fluid at the fluid detection location associated with the sensor). A sensor value above 9000 may indicate that no fluid or-55- 4923-4563-8928.1Atty. Dkt. No.: 86357077substantially no fluid is detected and may correspond to a low or zero wetness value. A sensor value between 6000 and 9000 may indicate a wetness value above zero but below the threshold, indicating that the channel may be partially filled with fluid at the fluid detection location associated with the sensor. In some examples, upon confirming that fluid is detected simultaneously at the first, upstream detection location, and the second, downstream detection location in operation 1708 and that the wetness value detected by the first (upstream) fluid detection sensor exceeds a first threshold for an entire time period between a first initial detection of the sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor, the method 1700 may proceed to operation 1716, and at least the portion of the sample fluid may be moved into the lysis chamber (e.g., lysis chamber 432).
[0157] If the sample fluid is not detected simultaneously at the first, upstream detection location, and the second, downstream detection location in operation 1708, or the wetness value detected by the first (upstream) fluid detection sensor does not exceed a first threshold for an entire time period between a first initial detection of the sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor, the method 1700 may proceed to operation 1712 and / or operation 1714. In some examples, if the sample fluid is not detected simultaneously at the first, upstream detection location, and the second, downstream detection location in operation 1708, or the wetness value detected by the first (upstream) fluid detection sensor does not exceed a first threshold for an entire time period between a first initial detection of the sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor, the controller 141 may cause the pump to stop supplying air to the pressurization channel 419 and the sample input chamber 412 when the sample fluid is detected by the second (downstream) fluid detection sensor, such that the leading end of the sample fluid stops at the second (downstream) location during operations 712 and / or 714.
[0158] At operation 1712 of the method 1700, if the sample fluid is not detected simultaneously at the first, upstream detection location, and the second, downstream detection location in operation 1708, or the wetness value detected by the first (upstream) fluid detection sensor does not exceed a first threshold for an entire time period between a first initial detection of the-56- 4923-4563-8928.1Atty. Dkt. No.: 86357077sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor, additional sample fluid is moved into or attempted to be moved into the fluidic channel (e.g., the metering channel). For example, the controller 141 may continue to cause the pump 402 to pressurize the pressurization channel 419 and the sample input chamber 412 to attempt to move additional sample fluid into the metering channel 421. For example, as discussed above with respect to FIGS. 11 and 12, if an air bubble or air pocket is present in the portion of the sample moved into the metering channel 421 in operation 1702, the sample may be detected simultaneously at the upstream sensor 428a and the downstream sensor 428b at operation 1708. However, at operation 1710, a wetness value detected below the threshold may be detected by the upstream sensor 428a during the time period between the first initial detection of the sample fluid by the upstream sensor 428a and a second initial detection of the sample fluid by the downstream sensor 428b.
[0159] In operation 1712, the controller 141 may be configured to estimate the volume of the portion of the sample fluid between the first, upstream detection location, and the second, downstream detection location based on the amount of time, during the time period between the first initial detection of the sample fluid by the upstream sensor 428a and a second initial detection of the sample fluid by the downstream sensor 428b, that the wetness value at the first, upstream detection location exceeds the first threshold. In some examples, the estimated volume of the portion of the sample fluid may be determined based on the average wetness value at the first, upstream detection location during the time period between the first initial detection of the sample fluid by the upstream sensor 428a and a second initial detection of the sample fluid by the downstream sensor 428b. Based on the estimated volume of the portion of the sample, the controller 141 may operate the pump 402 for a period of time such that the volume of additional sample fluid moved into the metering channel 421 meets or exceeds the difference between the target sample volume and the estimated volume of the initial portion of the sample in the metering channel 421. For example, the controller 141 may determine, based on the first sensor data from the upstream sensor 428a, that the volume of the portion of the sample in the metering channel 421 is 250 microliters. If the target or threshold volume of the sample for analysis is 300 microliters, the controller 141 then operate the pump 402 for an amount of time expected to cause 50 additional microliters to move into the metering channel 421. The controller 141 may receive additional first sensor data from the upstream sensor 428a -57- 4923-4563-8928.1Atty. Dkt. No.: 86357077to determine whether fluid is detected at the first, upstream detection location for the entire time that the pump 402 is pushing additional sample fluid through the metering channel. If fluid is not detected during this period, it may be determined that the volume of the sample is not sufficient, or the pump 402 may be operated for additional time. The controller 141 may be configured to estimate the total volume of sample fluid moved into the metering channel 421.
[0160] At operation 1714 of the method 1700, a request for user instructions may be provided to a user interface. The user interface may be a user interface of the machine or a user interface of an external computing device (a smartphone, a tablet computer, a desktop computer, a laptop computer, etc.). The request for user instructions may be a request for instructions to continue with the analysis of the sample fluid, to attempt to move additional sample fluid into the metering channel 421, or to cancel the analysis. For example, if the sample fluid is not detected simultaneously at the first, upstream detection location, and the second, downstream detection location in operation 1708, or the wetness value detected by the first (upstream) fluid detection sensor does not exceed a first threshold for an entire time period between a first initial detection of the sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor, the pump may be stopped until instructions are received. The request for instructions may include the estimated volume of sample fluid in the metering channel 421 estimated in operation 1712. For example, if the wetness value detected by the first (upstream) fluid detection sensor does not exceed a first threshold for an entire time period between a first initial detection of the sample fluid by the first fluid detection sensor and a second initial detection of the sample fluid by the second (downstream) fluid detection sensor (indicating an air bubble or pocket in the sample fluid), the controller 141 may estimate the volume of the sample fluid in the metering channel 421 and provide the estimated volume with the request for instructions. A user may indicate (e.g., via the user interface) that the pump 402 should be operated for an additional amount of time to attempt to move additional sample fluid into the metering channel 421. After the controller 141 controls the pump 402 to attempt to move additional sample fluid into the metering channel 421 (e.g., in operation 1712), the controller 141 may provide an updated estimate of the total volume of sample fluid in the metering channel 421 with a second request for instructions. The user may then indicate (e.g., via the user interface) that the sample fluid should be moved into -58- 4923-4563-8928.1Atty. Dkt. No.: 86357077the lysis chamber 432 to continue the analysis process. In some examples, if the estimated total volume of sample fluid meets or exceeds a threshold volume, the controller 141 may control the pump 402 to move the sample fluid into the lysis chamber 432 without further user input. Thus, in such examples, user input may only be requested when the estimated volume of the sample fluid that has been moved into the metering channel 421 does not meet or exceed the threshold volume. As discussed above, analysis of a sample that does not meet or exceed the threshold volume may still provide sufficiently reliable results in some cases. The request or requests for instructions sent to the user in operation 1714 may inform the user that the sample does not meet or exceed the threshold volume while allowing the user to choose whether to continue with analysis. The controller 141 may create or revise a record to indicate that the estimated sample volume of the sample fluid is below the threshold volume and that the results of analysis may be relatively less accurate.
[0161] At operation 1716 of the method 1700, the sample fluid in the metering channel (e.g., at least the portion of the sample fluid) is moved into the lysis chamber. For example, the controller 141 may cause the valve 408a to close and the valve 408b to open (for example by controlling valve actuators configured to open and close the valves 408a, 408b). The controller 141 may then control the pump 402 to pressurize the pressurization channel 419, thereby pressurizing the buffer fluid blister device 422 causing the buffer fluid to flow into the metering channel 421, pushing at least the portion of the sample fluid in the metering channel 421 into the lysis chamber 432. The pump 402 may continue to pressurize the blister device 422 until the buffer fluid (or at least a portion of the buffer fluid) also moves into the lysis chamber 432.
[0162] At operation 1718, a sonicator is caused to agitate at least the portion of the sample fluid in the lysis chamber. For example, the controller 141 may control the sonicator 133 to agitate at least the portion of the sample fluid in the lysis chamber 432 by causing the ultrasonic horn 434 to generate ultrasonic waves in the lysis chamber 432. As discussed above, the lysis chamber 432 may include a mixture of sample fluid and buffer fluid when the sonicator 133 agitates at least the portion of the sample fluid in the lysis chamber 432. Agitation of the sample fluid may cause biological cells in the sample fluid to be lysed. After operation 1718, downstream processes may be conducted to analyze the sample (e.g., blocks 630-640 of method 600).-59- 4923-4563-8928.1Atty. Dkt. No.: 86357077
[0163] As an example of the method 1700, the controller 141 in operation 1702 may cause the pump 402 pump to move at least a portion of a sample fluid in a first fluid chamber (e.g., the sample input chamber 412) of the cartridge 100 through the fluidic channel (e.g., the metering channel 421). Based on first sensor data from a first fluid detection sensor (upstream sensor 428a) monitored at operation 1704 and second sensor data from a second fluid detection sensor (upstream sensor 428a) monitored at operation 1706, the controller 141 may determine whether at least the portion of the sample fluid is simultaneously detected by the first fluid detection sensor and the second fluid detection sensor at operation 1708. Based on determining at operation 1708 that at least the portion of the sample fluid is simultaneously detected by the first fluid detection sensor and the second fluid detection sensor, the controller 141 may control the pump 402 to move at least the portion of the sample fluid into the lysis chamber 432 of the cartridge 100 at operation 1716. Then, at operation 1718, the controller 141 may cause the sonicator 133 to agitate at least the portion of the sample fluid in the lysis chamber 432.
[0164] In some examples, the controller 141 may determine at operation 1710, based on the first sensor data and the second sensor data, whether a wetness value of the first detection location (e.g., the upstream fluid detection location 149) exceeds a first threshold for an entire time period between a first initial detection of fluid by the first fluid detection sensor (e.g., upstream sensor 428a) and a second initial detection of fluid by the second fluid detection sensor (e.g., downstream sensor 428b). The controller 141 causing the pump to move at least the portion of the sample fluid into the lysis chamber 432 at operation 1716 may be further based on determining that the wetness value of the first detection location exceeds the first threshold for the entire time period.
[0165] In some examples, the controller 141 may detect at operation 1710, after a first initial detection of fluid by the first fluid detection sensor and based on the first sensor data, a first de-wetting event in which a wetness value of the first detection location falls below a first threshold, and may detect, after the first de-wetting event and before an initial detection of fluid by the second fluid detection sensor based on the first sensor data, a re-wetting event in which the wetness value of the first detection location exceeds the first threshold. A “de-wetting event” may refer to a decrease in the amount of fluid detected at the upstream detection location or downstream detection location. For example, a de-wetting event may correspond to a change-60- 4923-4563-8928.1Atty. Dkt. No.: 86357077in a sensor value (e.g., from below a threshold value to above the threshold value) indicating that less fluid is now detected than was previously detected. A “wetting event” or “re-wetting event” may refer to an increase in the amount of fluid detected at the upstream detection location or downstream detection location. As discussed above, the detection of a de-wetting event and a re-wetting event may indicate the presence of an air bubble or air pocket in at least the portion of the fluid sample. In this case, the controller 141 causing the pump 402 to move at least the portion of the sample fluid into the lysis chamber is further based on at least one additional operation of the controller 141. For example, the at least one additional operation of the controller 141 may include estimating a volume of at least the portion of the fluid sample in the fluidic channel 421 based on an amount of time between the first de-wetting event and the re-wetting event. The controller 141 may send the estimated volume of at least the portion of the fluid sample and a request for instructions to a user interface. A user may provide the instructions, via the user interface, to the controller responding to the request. In some examples, the instructions may be instructions to proceed with moving at least the portion of the sample fluid into the lysis chamber 432. In some examples, the instructions may be instructions to attempt to move additional sample fluid into the metering channel 421. Moving at least the portion of the sample fluid into the metering channel 421 in operation 1716 may further be based on receiving an instruction to proceed via the user interface. In some examples, the instructions may be instructions to eject the cartridge 100 and end the sample analysis process.
[0166] In some examples, rather than or in addition to estimating the volume of at least the portion of the sample fluid in the fluidic channel 421, additional operations performed by the controller 141 may include estimating the volume of air in the fluidic channel 421 (which may be equal to the difference between the volume of the fluidic channel and the estimated volume of fluid in the fluidic channel 421). The controller 141 may cause the pump 402 to attempt to move additional sample into the fluidic channel 421. The controller 141 may estimate, based on the first sensor data, the volume of the additional sample fluid moved into the fluidic channel 421, for example, based on the wetness value detected by the upstream sensor 428a while the pump 402 is operated to attempt to move the additional sample fluid into the fluidic channel 421. The controller 141 may determine whether the estimated volume of the additional sample fluid exceeds the estimated volume of air. As discussed above, the volume of the metering -61- 4923-4563-8928.1Atty. Dkt. No.: 86357077channel 421 between the first, upstream detection location, and the second, downstream detection location, may be equal to or may exceed a target or threshold volume for sample analysis. Moving at least the portion of the sample fluid into the metering channel 421 in operation 1716 may be further based on determining that the estimated volume of the additional sample fluid exceeds the estimated volume of air, indicating that the total volume of sample fluid exceeds the threshold volume. In some examples, rather than comparing the estimated volume of air to the estimated volume of additional sample fluid, the controller 141 may add the estimated volume of at least the portion of the sample fluid to the estimate volume of the additional sample fluid. Moving at least the portion of the sample fluid into the lysis chamber 432 may further include determining, by the controller 141, that the sum of the estimated volume of at least the portion of the sample fluid and the estimated volume of the additional sample fluid exceeds the threshold volume.
[0167] As discussed above, the controller 141 may detect, based on the first and second sensor data, after a first initial detection of fluid by the first fluid detection sensor 428a and based on the first sensor data, a first de-wetting event in which a wetness value of the first detection location falls below a first threshold. In some examples, a re-wetting event may not be detected before an initial detection of the sample fluid by the downstream sensor 428b, which may indicate that there is air trailing at least the portion of the sample fluid in the metering channel 421. The controller 141 may estimate a volume of at least the portion of the fluid sample in the fluidic channel 421 based on an amount of time between the first initial detection by the upstream sensor 428a and the first de-wetting event. The controller 141 may then send the estimated volume of at least the portion of the fluid sample and a request for instructions to the user interface, as discussed above. The controller 141 may receive, from the user interface, instructions to proceed with moving at least the portion of the sample fluid into the lysis chamber 432 and, based on receiving the instructions to proceed, may cause the pump 402 to move at least the portion of the sample fluid into the lysis chamber 432 at operation 1716. In other examples, when the de-wetting event is detected, the controller 141 may estimate the volume of air in the fluidic channel 421 as discussed above, may cause the pump 402 to move additional sample fluid into the fluidic channel 421 after the second initial detection of fluid, may estimate, based on the first sensor data, a volume of the additional sample fluid, may determine whether the estimated volume of the additional sample fluid exceeds the estimated -62- 4923-4563-8928.1Atty. Dkt. No.: 86357077volume of air, and based on determining that the estimated volume of the additional sample fluid exceeds the estimated volume of air, may cause the pump 402 to move at least the portion of the sample fluid into the lysis chamber 432 at operation 1716. Moving additional fluid into the fluidic channel 421 may be performed automatically upon detecting the de-wetting event or in response to instructions via the user interface.
[0168] The phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” “having,” “containing,” “involving,” “characterized by,” “characterized in that,” and variations thereof herein, is meant to encompass the items listed thereafter, equivalents thereof, and additional items, as well as alternate implementations consisting of the items listed thereafter exclusively. In one implementation, the systems and methods described herein consist of one, each combination of more than one, or all of the described elements, acts, or components.
[0169] References to “or” may be construed as inclusive so that any terms described using “or” may indicate any of a single, more than one, and all of the described terms. References to at least one of a conjunctive list of terms may be construed as an inclusive OR to indicate any of a single, more than one, and all of the described terms. For example, a reference to “at least one of ‘A’ and ‘B’” can include only ‘A,’ only ‘B,’ as well as both ‘A’ and ‘B.’ Such references used in conjunction with "comprising" or other open terminology can include additional items. References to “is” or “are” may be construed as nonlimiting to the implementation or action referenced in connection with that term. The terms “is” or “are” or any tense or derivative thereof, are interchangeable and synonymous with "can be" as used herein, unless stated otherwise herein.
[0170] Directional indicators depicted herein are example directions to facilitate understanding of the examples discussed herein and are not limited to the directional indicators depicted herein. Any directional indicator depicted herein can be modified to the reverse direction or can be modified to include both the depicted direction and a direction reverse to the depicted direction, unless stated otherwise herein. While operations are depicted in the drawings in a particular order, such operations are not required to be performed in the particular order shown or in sequential order, and all illustrated operations are not required to be performed. Actions-63- 4923-4563-8928.1Atty. Dkt. No.: 86357077described herein can be performed in a different order. Where technical features in the drawings, detailed description or any claim are followed by reference signs, the reference signs have been included to increase the intelligibility of the drawings, detailed description, and claims. Accordingly, neither the reference signs nor their absence have any limiting effect on the scope of any claim elements.
[0171] The various ranges provided herein include the stated range and any value or sub-range within the stated range. Furthermore, when “about” is utilized to describe a value or percentage this includes, refers to, and / or encompasses variations (up to + / - ten %) from the stated value or percentage. In describing and claiming the examples disclosed herein, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
[0172] Although specific examples have been illustrated and described herein, a variety of alternate and / or equivalent implementations may be substituted for the specific examples shown and described without departing from the scope of the present disclosure. This application is intended to cover any adaptations or variations of the specific examples discussed herein. For example, the method 200 may include additional operations not explicitly recited or may exclude certain recited operations in some examples. Various examples of the cartridge 100 or the instrument 150 may include additional components not explicitly recited, may exclude certain recited components, or may include the recited components in different relative positions than shown in the examples described above. Therefore, it is intended that the scope of this disclosure be limited only by the claims and the equivalents thereof.-64- 4923-4563-8928.1
Claims
Atty. Dkt. No.: 86357077WHAT IS CLAIMED IS:
1. A diagnostic system comprising:an instrument to interface with a cartridge, the instrument comprising:a pump;a sonicator;a first fluid detection sensor to detect fluid at a first detection location in a fluidic channel of the cartridge and generate first sensor data;a second fluid detection sensor to detect fluid at a second detection location in the fluidic channel downstream of the first detection location and generate second sensor data; anda controller to:cause the pump to move at least a portion of a sample fluid in a first fluid chamber of the cartridge through the fluidic channel;determine, based on the first sensor data and the second sensor data, whether at least the portion of the sample fluid is simultaneously detected by the first fluid detection sensor and the second fluid detection sensor;based on determining that at least the portion of the sample fluid is simultaneously detected by the first fluid detection sensor and the second fluid detection sensor, cause the pump to move at least the portion of the sample fluid into a lysis chamber of the cartridge; andresponsive to moving at least the portion of the sample fluid into a lysis chamber, cause the sonicator to agitate at least the portion of the sample fluid in the lysis chamber.
2. The diagnostic system of claim 1, wherein causing the pump to move at least the portion of the sample fluid into the lysis chamber is further based on determining, by the controller and based on the first sensor data and the second sensor data, that a wetness value of the first detection location exceeds a first threshold for an entire time period between a first initial detection of fluid by the first fluid detection sensor and a second initial detection of fluid by the second fluid detection sensor.-65- 4923-4563-8928.1Atty. Dkt. No.: 863570773. The diagnostic system of claim 1, wherein the controller is further to:detect, after a first initial detection of fluid by the first fluid detection sensor and based on the first sensor data, a first de-wetting event in which a wetness value of the first detection location falls below a first threshold; anddetect, after the first de-wetting event and before an initial detection of fluid by the second fluid detection sensor based on the first sensor data, a re-wetting event in which the wetness value of the first detection location exceeds the first threshold,wherein when the first de-wetting event and the re-wetting event are detected, causing the pump to move at least the portion of the sample fluid into the lysis chamber is further based on at least one additional operation of the controller.
4. The diagnostic system of claim 3, wherein the at least one additional operation comprises:estimating a volume of at least the portion of the fluid sample in the fluidic channel based on an amount of time between the first de-wetting event and the re-wetting event; sending, to a user interface, the estimated volume of at least the portion of the fluid sample in the fluidic channel and request for instructions; andreceiving, from the user interface, instructions to proceed with moving at least the portion of the sample fluid into the lysis chamber.
5. The diagnostic system of claim 3, wherein the at least one additional operation comprises:estimating a volume of air in the fluidic channel based on an amount of time between the first de-wetting event and the re-wetting event;causing the pump to move additional sample fluid into the fluidic channel; estimating, based on the first sensor data, a volume of the additional sample fluid; and determining that the estimated volume of the additional sample fluid exceeds the estimated volume of air.
6. The diagnostic system of claim 1, wherein the controller is further to:-66- 4923-4563-8928.1Atty. Dkt. No.: 86357077detect, after a first initial detection of fluid by the first fluid detection sensor and based on the first sensor data, a first de-wetting event in which a wetness value of the first detection location falls below a first threshold;estimate a volume of at least the portion of the fluid sample in the fluidic channel based on an amount of time between the first initial detection and the first de-wetting event;send, to a user interface, the estimated volume of at least the portion of the fluid sample and a request for instructions;receive, from the user interface, instructions to proceed with moving at least the portion of the sample fluid into the lysis chamber; andbased on receiving the instructions to proceed, causing the pump to move at least the portion of the sample fluid into a lysis chamber of the cartridge.
7. The diagnostic system of claim 1, wherein the controller is further to:detect, after a first initial detection of fluid by the first fluid detection sensor and based on the first sensor data, a first de-wetting event in which a wetness value of the first detection location falls below a first threshold;estimate a volume of air in the fluidic channel based on an amount of time between the first de-wetting event and a second initial detection of fluid by the second fluid detection sensor;cause the pump to move additional sample fluid into the fluidic channel after the second initial detection of fluid;estimate, based on the first sensor data, a volume of the additional sample fluid;determine whether the estimated volume of the additional sample fluid exceeds the estimated volume of air; andbased on determining that the estimated volume of the additional sample fluid exceeds the estimated volume of air, cause the pump to move at least the portion of the sample fluid into a lysis chamber of the cartridge.-67- 4923-4563-8928.1Atty. Dkt. No.: 863570778. A method of analyzing a sample fluid, the method comprising:moving at least a portion of the sample fluid through a fluidic channel in a downstream direction over a first detection location and to a second detection location downstream of the first detection location;monitoring first sensor data from a first fluid detection sensor positioned to detect fluid at the first detection location;monitoring second sensor data from a second fluid detection sensor positioned to detect fluid at the second detection location;determining, based on the first sensor data and the second sensor data, that at least the portion of the sample fluid is detected simultaneously at the first detection location and the second detection location;based on determining that at least the portion of the sample fluid is detected simultaneously at the first detection location and the second detection location, moving at least the portion of the sample fluid into a lysis chamber fluidly coupled to the fluidic channel downstream of the second detection location; andagitating the fluid in the lysis chamber.
9. The method of claim 8, wherein moving at least the portion of the sample fluid into a lysis chamber is further based on determining, based on the first sensor data, that a wetness value of the first detection location exceeds a first threshold for an entire time period between a first initial detection of fluid by the first fluid detection sensor and a second initial detection of fluid by the second fluid detection sensor.
10. The method of claim 8, further comprising:detecting, after a first initial detection of fluid by the first fluid detection sensor and based on the first sensor data, a first de-wetting event in which a wetness value of the first detection location falls below a first threshold;detecting, after the first de-wetting event and before an initial detection of fluid by the second fluid detection sensor based on the first sensor data, a re-wetting event in which the wetness value of the first detection location exceeds the first threshold; and-68- 4923-4563-8928.1Atty. Dkt. No.: 86357077estimating a volume of at least the portion of the sample fluid in the fluidic channel based on an amount of time between the first de-wetting event and the re-wetting event.
11. The method of claim 10, further comprising:providing the estimated volume of the of at least the portion of the sample fluid and a request for instructions to a user interface, wherein moving at least the portion of the sample fluid into the lysis chamber is further based on instructions received from the user interface in response to the request.
12. The method of claim 10, further comprising:moving additional sample fluid into the fluidic channel; andestimating, based on the first sensor data, a volume of the additional sample fluid moved into the fluidic channel, wherein moving at least the portion of the sample fluid into the lysis chamber further comprises determining that the sum of the estimated volume of at least the portion of the sample fluid and the estimated volume of the additional sample fluid exceeds a threshold volume.
13. A diagnostic system comprising:a cartridge comprising:a sample input chamber to receive a sample fluid;a lysis chamber; anda fluidic channel fluidly coupling the sample input chamber and the lysis chamber; andan instrument to interface with the cartridge, the instrument comprising:a pump;a sonicator;a first sensor to detect a wetness value of a first detection location in the fluidic channel;a second sensor to detect a wetness value of a second detection location in the fluidic channel; and-69- 4923-4563-8928.1Atty. Dkt. No.: 86357077a controller to:cause the pump to move at least a portion of the sample fluid through the fluidic channel;receive first sensor data from the first sensor comprising the wetness value of the first detection location over time and second sensor data from the second sensor comprising the wetness value of the second detection location over time;determine, based on the first sensor data and the second sensor data, whether the wetness value of the first detection location exceeds a first threshold and the wetness value of the second detection location exceeds a second threshold simultaneously;based on determining that the wetness value of the first detection location exceeds the first threshold and the wetness value of the second detection location exceeds the second threshold simultaneously, cause the pump to move at least the portion of the sample fluid into the lysis chamber; andcause the sonicator to agitate at least the portion of the sample fluid in the lysis chamber.
14. The diagnostic system of claim 13, wherein the controller is further to:detect, after a first initial detection of fluid by the first sensor and based on the first sensor data, a first de-wetting event in which the wetness value of the first detection location falls below a first threshold;estimate a volume of at least the portion of the sample fluid in the fluid detection channel based on a duration of the first de-wetting event before a second initial detection of fluid by the second sensor; andprovide the estimated volume and a request for instructions to a user interface.
15. The diagnostic system of claim 14, wherein the controller is further to:receive, from the user interface, the requested instruction; andin response to receiving the requested instructions, cause the instrument to eject the cartridge, cause the pump to move additional sample fluid into the fluidic channel, or cause the pump to move at least the portion of the sample fluid into the lysis chamber.-70- 4923-4563-8928.1
